,title,authors,affiliations,URL
0,Original research: Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer,"Tsukasa Masuda, Nobuyuki Tanaka, Kimiharu Takamatsu, Kyohei Hakozaki, Ryohei Takahashi, Tadatsugu Anno, Ryohei Kufukihara, Kazunori Shojo, Shuji Mikami, Toshiaki Shinojima, Kazuhiro Kakimi, Tatsuhiko Tsunoda, Eriko Aimono, Hiroshi Nishihara, Ryuichi Mizuno, Mototsugu Oya","Tsukasa Masuda Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan PubMed articlesGoogle scholar articles; Kimiharu Takamatsu Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan PubMed articlesGoogle scholar articles; Ryohei Takahashi Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan PubMed articlesGoogle scholar articles; Ryohei Kufukihara Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan PubMed articlesGoogle scholar articles; Shuji Mikami Department of Diagnostic Pathology, Keio University Hospital, Tokyo, Japan PubMed articlesGoogle scholar articles; Kazuhiro Kakimi Department of Immuno-therapeutics, The University of Tokyo Hospital, Tokyo, Japan PubMed articlesGoogle scholar articles; Eriko Aimono Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles; Ryuichi Mizuno Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan PubMed articlesGoogle scholar articles; Nobuyuki Tanaka Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan PubMed articlesGoogle scholar articles; Kyohei Hakozaki Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan PubMed articlesGoogle scholar articles; Tadatsugu Anno Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan PubMed articlesGoogle scholar articles; Kazunori Shojo Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan PubMed articlesGoogle scholar articles; Toshiaki Shinojima Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanDepartment of Urology, Saitama Medical University, Moroyama, Saitama PubMed articlesGoogle scholar articles; Tatsuhiko Tsunoda Department of Medical Science Mathematics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, JapanLaboratory for Medical Science Mathematics, Department of Biological Sciences, TheGraduate School of Science, The University of Tokyo, Tokyo, JapanLaboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan PubMed articlesGoogle scholar articles; Hiroshi Nishihara Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles; Mototsugu Oya Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003883
1,Original research: STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice,"Rebekka Bitsch, Annina Kurzay, Feyza Özbay Kurt, Carolina De La Torre, Samantha Lasser, Alisa Lepper, Alina Siebenmorgen, Verena Müller, Peter Altevogt, Jochen Utikal, Viktor Umansky","Rebekka Bitsch Skin Cancer Unit/ Department of Dermatology, Venerology and Allergology, German Cancer Research Center (DKFZ), University Medical Centre Mannheim, Heidelberg, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDKFZ-Hector Cancer Institute, University Medical Centre Mannheim, Mannheim, Germany PubMed articlesGoogle scholar articles; Feyza Özbay Kurt Skin Cancer Unit/ Department of Dermatology, Venerology and Allergology, German Cancer Research Center (DKFZ), University Medical Centre Mannheim, Heidelberg, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDKFZ-Hector Cancer Institute, University Medical Centre Mannheim, Mannheim, GermanyFaculty of Biosciences, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles; Samantha Lasser Skin Cancer Unit/ Department of Dermatology, Venerology and Allergology, German Cancer Research Center (DKFZ), University Medical Centre Mannheim, Heidelberg, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDKFZ-Hector Cancer Institute, University Medical Centre Mannheim, Mannheim, GermanyFaculty of Biosciences, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles; Alina Siebenmorgen Skin Cancer Unit/ Department of Dermatology, Venerology and Allergology, German Cancer Research Center (DKFZ), University Medical Centre Mannheim, Heidelberg, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDKFZ-Hector Cancer Institute, University Medical Centre Mannheim, Mannheim, Germany PubMed articlesGoogle scholar articles; Peter Altevogt Skin Cancer Unit/ Department of Dermatology, Venerology and Allergology, German Cancer Research Center (DKFZ), University Medical Centre Mannheim, Heidelberg, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDKFZ-Hector Cancer Institute, University Medical Centre Mannheim, Mannheim, Germany PubMed articlesGoogle scholar articles; Viktor Umansky Skin Cancer Unit/ Department of Dermatology, Venerology and Allergology, German Cancer Research Center (DKFZ), University Medical Centre Mannheim, Heidelberg, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDKFZ-Hector Cancer Institute, University Medical Centre Mannheim, Mannheim, Germany PubMed articlesGoogle scholar articles; Annina Kurzay Skin Cancer Unit/ Department of Dermatology, Venerology and Allergology, German Cancer Research Center (DKFZ), University Medical Centre Mannheim, Heidelberg, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDKFZ-Hector Cancer Institute, University Medical Centre Mannheim, Mannheim, Germany PubMed articlesGoogle scholar articles; Carolina De La Torre NGS Core Facility, Medical Faculty Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles; Alisa Lepper Skin Cancer Unit/ Department of Dermatology, Venerology and Allergology, German Cancer Research Center (DKFZ), University Medical Centre Mannheim, Heidelberg, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDKFZ-Hector Cancer Institute, University Medical Centre Mannheim, Mannheim, Germany PubMed articlesGoogle scholar articles; Verena Müller Skin Cancer Unit/ Department of Dermatology, Venerology and Allergology, German Cancer Research Center (DKFZ), University Medical Centre Mannheim, Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles; Jochen Utikal Skin Cancer Unit/ Department of Dermatology, Venerology and Allergology, German Cancer Research Center (DKFZ), University Medical Centre Mannheim, Heidelberg, Mannheim, GermanyDKFZ-Hector Cancer Institute, University Medical Centre Mannheim, Mannheim, Germany PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004384
2,Original research: TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy,"Pauline Hamon, Marine Gerbé De Thoré, Marion Classe, Nicolas Signolle, Winchygn Liu, Olivia Bawa, Lydia Meziani, Céline Clémenson, Fabien Milliat, Eric Deutsch, Michele Mondini","Pauline Hamon INSERM U1030, Gustave Roussy, Université Paris-Saclay, Villejuif, France PubMed articlesGoogle scholar articles; Marion Classe INSERM U1030, Gustave Roussy, Université Paris-Saclay, Villejuif, FranceDépartment de Pathologie, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Winchygn Liu INSERM U1030, Gustave Roussy, Université Paris-Saclay, Villejuif, France PubMed articlesGoogle scholar articles; Lydia Meziani INSERM U1030, Gustave Roussy, Université Paris-Saclay, Villejuif, France PubMed articlesGoogle scholar articles; Fabien Milliat Department of RAdiobiology and Regenerative MEDicine (SERAMED), Laboratory of MEDical Radiobiology (LRMed), Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, France PubMed articlesGoogle scholar articles; Michele Mondini INSERM U1030, Gustave Roussy, Université Paris-Saclay, Villejuif, France PubMed articlesGoogle scholar articles; Marine Gerbé De Thoré INSERM U1030, Gustave Roussy, Université Paris-Saclay, Villejuif, France PubMed articlesGoogle scholar articles; Nicolas Signolle Plateforme de pathologie expérimentale et translationnelle, UMS AMMICA, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Olivia Bawa Départment de Pathologie, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Céline Clémenson INSERM U1030, Gustave Roussy, Université Paris-Saclay, Villejuif, France PubMed articlesGoogle scholar articles; Eric Deutsch INSERM U1030, Gustave Roussy, Université Paris-Saclay, Villejuif, FranceDépartement d’Oncologie-Radiothérapie, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003519
3,IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells,"Nadine Landolina, Francesca Romana Mariotti, Tiziano Ingegnere, Claudia Alicata, Biancamaria Ricci, Andrea Pelosi, Irene Veneziani, Bruno Giuseppe Azzarone, Cecilia Garlanda, Alberto Mantovani, Lorenzo Moretta, Enrico Maggi","Nadine Landolina Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy PubMed articlesGoogle scholar articles; Tiziano Ingegnere Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy PubMed articlesGoogle scholar articles; Biancamaria Ricci Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy PubMed articlesGoogle scholar articles; Irene Veneziani Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy PubMed articlesGoogle scholar articles; Cecilia Garlanda Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), ItalyIRCCS Humanitas Research Hospital, Humanitas University, Rozzano (Milan), Italy PubMed articlesGoogle scholar articles; Lorenzo Moretta Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy PubMed articlesGoogle scholar articles; Francesca Romana Mariotti Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy PubMed articlesGoogle scholar articles; Claudia Alicata Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy PubMed articlesGoogle scholar articles; Andrea Pelosi Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy PubMed articlesGoogle scholar articles; Bruno Giuseppe Azzarone Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy PubMed articlesGoogle scholar articles; Alberto Mantovani Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), ItalyIRCCS Humanitas Research Hospital, Humanitas University, Rozzano (Milan), ItalyThe William Harvey Research Institute, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles; Enrico Maggi Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003858
4,Original research: ZEB1 transcription factor promotes immune escape in melanoma,"Maud Plaschka, Valentin Benboubker, Maxime Grimont, Justine Berthet, Laurie Tonon, Jonathan Lopez, Myrtille Le-Bouar, Brigitte Balme, Garance Tondeur, Arnaud de la Fouchardière, Lionel Larue, Alain Puisieux, Yenkel Grinberg-Bleyer, Nathalie Bendriss-Vermare, Bertrand Dubois, Christophe Caux, Stéphane Dalle, Julie Caramel","Maud Plaschka Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles; Maxime Grimont Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles; Laurie Tonon Fondation Synergie Lyon Cancer, Plateforme de bio-informatique Gilles Thomas, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles; Myrtille Le-Bouar Dermatology Unit, Hospices Civils de Lyon, CH Lyon Sud, Pierre Bénite, France PubMed articlesGoogle scholar articles; Garance Tondeur Dermatology Unit, Hospices Civils de Lyon, CH Lyon Sud, Pierre Bénite, France PubMed articlesGoogle scholar articles; Lionel Larue Institut Curie, PSL Research University, Paris, France PubMed articlesGoogle scholar articles; Yenkel Grinberg-Bleyer Molecular Regulation of Immunity in Cancer, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles; Bertrand Dubois Cancer Immune Surveillance and Therapeutic Targeting, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, FranceLaboratory of Immunotherapy of Cancer of Lyon (LICL), Lyon, France PubMed articlesGoogle scholar articles; Stéphane Dalle Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, FranceDermatology Unit, Hospices Civils de Lyon, CH Lyon Sud, Pierre Bénite, France PubMed articlesGoogle scholar articles; Valentin Benboubker Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles; Justine Berthet Cancer Immune Surveillance and Therapeutic Targeting, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, FranceLaboratory of Immunotherapy of Cancer of Lyon (LICL), Lyon, France PubMed articlesGoogle scholar articles; Jonathan Lopez Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles; Brigitte Balme Dermatology Unit, Hospices Civils de Lyon, CH Lyon Sud, Pierre Bénite, France PubMed articlesGoogle scholar articles; Arnaud de la Fouchardière Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles; Alain Puisieux Institut Curie, PSL Research University, Paris, France PubMed articlesGoogle scholar articles; Nathalie Bendriss-Vermare Cancer Immune Surveillance and Therapeutic Targeting, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, FranceLaboratory of Immunotherapy of Cancer of Lyon (LICL), Lyon, France PubMed articlesGoogle scholar articles; Christophe Caux Cancer Immune Surveillance and Therapeutic Targeting, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, FranceLaboratory of Immunotherapy of Cancer of Lyon (LICL), Lyon, France PubMed articlesGoogle scholar articles; Julie Caramel Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003484
5,"Original research: Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer","Theodoros Michelakos, Filippos Kontos, Tomohiro Kurokawa, Lei Cai, Ananthan Sadagopan, Danielle Krijgsman, Wilko Weichert, Lindy G Durrant, Peter J K Kuppen, Cristina R Ferrone, Soldano Ferrone","Theodoros Michelakos Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Tomohiro Kurokawa Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Ananthan Sadagopan Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Wilko Weichert Institute of Pathology, Technical University Munich, Munich, Germany PubMed articlesGoogle scholar articles; Peter J K Kuppen Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Soldano Ferrone Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Filippos Kontos Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Lei Cai Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Danielle Krijgsman Department of Surgery, Leiden University Medical Center, Leiden, The NetherlandsMolecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, The Netherlands PubMed articlesGoogle scholar articles; Lindy G Durrant Academic Department of Clinical Oncology, University of Nottingham, City Hospital, Nottingham, UK PubMed articlesGoogle scholar articles; Cristina R Ferrone Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004115
6,Original research: Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents,"Roberta Turiello, Mariaelena Capone, Elva Morretta, Maria Chiara Monti, Gabriele Madonna, Rosa Azzaro, Pasquale Del Gaudio, Ester Simeone, Antonio Sorrentino, Paolo A Ascierto, Silvana Morello","Roberta Turiello Department of Pharmacy, University of Salerno, Fisciano, ItalyPhD Program in Drug Discovery and Development, University of Salerno, Fisciano, Italy PubMed articlesGoogle scholar articles; Elva Morretta Department of Pharmacy, University of Salerno, Fisciano, Italy PubMed articlesGoogle scholar articles; Gabriele Madonna Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Pasquale Del Gaudio Department of Pharmacy, University of Salerno, Fisciano, Italy PubMed articlesGoogle scholar articles; Antonio Sorrentino Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Silvana Morello Department of Pharmacy, University of Salerno, Fisciano, Italy PubMed articlesGoogle scholar articles; Mariaelena Capone Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Maria Chiara Monti Department of Pharmacy, University of Salerno, Fisciano, Italy PubMed articlesGoogle scholar articles; Rosa Azzaro Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Ester Simeone Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Paolo A Ascierto Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004043
7,Original research: Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S,"Tom J Harryvan, Marten Visser, Linda de Bruin, Léonie Plug, Lisa Griffioen, Arend Mulder, Peter A van Veelen, Gerbrand J van der Heden van Noort, Marlieke LM Jongsma, Miranda H Meeuwsen, Emmanuel JHJ Wiertz, Saskia J Santegoets, James CH Hardwick, Thorbald Van Hall, Jacques Neefjes, Sjoerd H Van der Burg, Lukas JAC Hawinkels, Els ME Verdegaal","Tom J Harryvan Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Linda de Bruin Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Lisa Griffioen Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Peter A van Veelen Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Marlieke LM Jongsma Department of Cell & Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Emmanuel JHJ Wiertz Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles; James CH Hardwick Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Jacques Neefjes Department of Cell & Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Lukas JAC Hawinkels Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Marten Visser Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Léonie Plug Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Arend Mulder Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Gerbrand J van der Heden van Noort Department of Cell & Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Miranda H Meeuwsen Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Saskia J Santegoets Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Thorbald Van Hall Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Sjoerd H Van der Burg Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Els ME Verdegaal Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003591
8,Original research: PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment,"Natalie B Collins, Rose Al Abosy, Brian C Miller, Kevin Bi, Qihong Zhao, Michael Quigley, Jeffrey J Ishizuka, Kathleen B Yates, Hans W Pope, Robert T Manguso, Yashaswi Shrestha, Marc Wadsworth, Travis Hughes, Alex K Shalek, Jesse S Boehm, William C Hahn, John G Doench, W Nicholas Haining","Natalie B Collins Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USADana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Brian C Miller Lineberger Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles; Qihong Zhao Oncology Discovery Biology, Bristol Myers Squibb, Lawrenceville, New Jersey, USA PubMed articlesGoogle scholar articles; Jeffrey J Ishizuka Department of Internal Medicine (Oncology), Yale Cancer Center and Yale School of Medicine, New Haven, New Jersey, USA PubMed articlesGoogle scholar articles; Hans W Pope Arsenal Biosciences, San Francisco, California, USA PubMed articlesGoogle scholar articles; Yashaswi Shrestha AstraZeneca, Gaithersburg, Maryland, USA PubMed articlesGoogle scholar articles; Travis Hughes Broad Institute, Cambridge, Massachusetts, USAInstitute for Medical Engineering & Science (IMES), Department of Chemistry and Koch Institute for Integrative Cancer Research, Ragon Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USARagon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Jesse S Boehm Broad Institute, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles; John G Doench Broad Institute, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles; Rose Al Abosy Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Kevin Bi Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Michael Quigley Research Biology, Gilead Sciences Inc, Foster City, California, USA PubMed articlesGoogle scholar articles; Kathleen B Yates Broad Institute, Cambridge, Massachusetts, USACenter for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA PubMed articlesGoogle scholar articles; Robert T Manguso Broad Institute, Cambridge, Massachusetts, USACenter for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA PubMed articlesGoogle scholar articles; Marc Wadsworth Broad Institute, Cambridge, Massachusetts, USAInstitute for Medical Engineering & Science (IMES), Department of Chemistry and Koch Institute for Integrative Cancer Research, Ragon Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USARagon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Alex K Shalek Broad Institute, Cambridge, Massachusetts, USAInstitute for Medical Engineering & Science (IMES), Department of Chemistry and Koch Institute for Integrative Cancer Research, Ragon Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USARagon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; William C Hahn Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USABroad Institute, Cambridge, Massachusetts, USADepartment of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; W Nicholas Haining Arsenal Biosciences, San Francisco, California, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003402
9,"Original research: Necroptosis-driving genes RIPK1, RIPK3 and MLKL-p are associated with intratumoral CD3+ and CD8+ T cell density and predict prognosis in hepatocellular carcinoma","Lorenzo Nicolè, Tiziana Sanavia, Rocco Cappellesso, Valeria Maffeis, Jun Akiba, Akihiko Kawahara, Yoshiki Naito, Claudia Maria Radu, Paolo Simioni, Davide Serafin, Giuliana Cortese, Maria Guido, Giacomo Zanus, Hirohisa Yano, Ambrogio Fassina","Lorenzo Nicolè 
Department of Medicine (DIMED), University of Padova, Padova, Italy

Department of Pathology, Angelo Hospital, Mestre, Italy
 PubMed articlesGoogle scholar articles; Rocco Cappellesso 
Department of Pathology, Padova University Hospital, Padova, Italy
 PubMed articlesGoogle scholar articles; Jun Akiba 
Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
 PubMed articlesGoogle scholar articles; Yoshiki Naito 
Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
 PubMed articlesGoogle scholar articles; Paolo Simioni 
Department of Medicine, General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, University of Padova, Padova, Italy
 PubMed articlesGoogle scholar articles; Giuliana Cortese 
Department of Statistical Sciences, University of Padova, Padova, Italy
 PubMed articlesGoogle scholar articles; Giacomo Zanus 
Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy

II Surgery Unit, Regional Hospital Treviso, Treviso, Italy
 PubMed articlesGoogle scholar articles; Ambrogio Fassina 
Department of Medicine (DIMED), University of Padova, Padova, Italy
 PubMed articlesGoogle scholar articles; Tiziana Sanavia 
Department of Medical Sciences, University of Torino, Torino, Italy
 PubMed articlesGoogle scholar articles; Valeria Maffeis 
Department of Pathology, Azienda ULSS2 Marca Trevigiana, Treviso, Italy
 PubMed articlesGoogle scholar articles; Akihiko Kawahara 
Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
 PubMed articlesGoogle scholar articles; Claudia Maria Radu 
Department of Medicine, General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, University of Padova, Padova, Italy
 PubMed articlesGoogle scholar articles; Davide Serafin 
Department of Statistical Sciences, University of Padova, Padova, Italy
 PubMed articlesGoogle scholar articles; Maria Guido 
Department of Medicine (DIMED), University of Padova, Padova, Italy

Department of Pathology, Azienda ULSS2 Marca Trevigiana, Treviso, Italy
 PubMed articlesGoogle scholar articles; Hirohisa Yano 
Department of Pathology, Kurume University School of Medicine, Kurume, Japan
 PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004031
10,Original research: System analysis based on the cancer–immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma,"Xu Wang, Tao Zhou, Xingyi Chen, Yu Wang, Yushi Ding, Haoyang Tu, Shengyang Gao, Haoyu Wang, Xinying Tang, Yong Yang","Xu Wang State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China PubMed articlesGoogle scholar articles; Xingyi Chen State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Yushi Ding State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Shengyang Gao State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Xinying Tang State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, ChinaDepartment of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Tao Zhou State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Yu Wang State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Haoyang Tu State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Haoyu Wang State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Yong Yang State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, ChinaDepartment of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004414
11,Original research: Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite,"Giorgia Renga, Emilia Nunzi, Marilena Pariano, Matteo Puccetti, Marina Maria Bellet, Giuseppe Pieraccini, Fiorella D’Onofrio, Ilaria Santarelli, Claudia Stincardini, Franco Aversa, Francesca Riuzzi, Cinzia Antognelli, Marco Gargaro, Oxana Bereshchenko, Maurizio Ricci, Stefano Giovagnoli, Luigina Romani, Claudio Costantini","Giorgia Renga 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Marilena Pariano 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Marina Maria Bellet 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Fiorella D’Onofrio 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Claudia Stincardini 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Francesca Riuzzi 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Marco Gargaro 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Maurizio Ricci 
Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Luigina Romani 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Emilia Nunzi 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Matteo Puccetti 
Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Giuseppe Pieraccini 
Department of Health Sciences, University of Florence, Firenze, Italy
 PubMed articlesGoogle scholar articles; Ilaria Santarelli 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Franco Aversa 
Department of Medicine and Surgery, University of Parma, Parma, Italy
 PubMed articlesGoogle scholar articles; Cinzia Antognelli 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Oxana Bereshchenko 
Department of Philosophy, Social Sciences and Education, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Stefano Giovagnoli 
Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles; Claudio Costantini 
Department of Medicine and Surgery, University of Perugia, Perugia, Italy
 PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003725
12,Spontaneous tumor regression following COVID-19 vaccination,"Luana Guimaraes de Sousa, Daniel J McGrail, Kaiyi Li, Mario L Marques-Piubelli, Cipriano Gonzalez, Hui Dai, Sammy Ferri-Borgogno, Myrna Godoy, Jared Burks, Shiaw-Yih Lin, Diana Bell, Renata Ferrarotto","Luana Guimaraes de Sousa Thoracic and Head and Neck, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Kaiyi Li Thoracic and Head and Neck, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Cipriano Gonzalez Thoracic and Head and Neck, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Sammy Ferri-Borgogno Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Jared Burks Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Diana Bell Pathology, City of Hope Comprehensive Cancer Center, Duarte, California, USA PubMed articlesGoogle scholar articles; Daniel J McGrail Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Mario L Marques-Piubelli Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Hui Dai Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Myrna Godoy Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Shiaw-Yih Lin Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Renata Ferrarotto Thoracic and Head and Neck, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004371
13,Original research: FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer,"Yang Zhang, Fan Huo, Qiang Cao, Ru Jia, Qiju Huang, Zhu A Wang, Dan Theodorescu, Qiang Lv, Pengchao Li, Chao Yan","Yang Zhang State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Qiang Cao Department of Urology, the First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital), Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Qiju Huang State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Dan Theodorescu Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USADepartment of Surgery (Urology), Cedars-Sinai Medical Center, Los Angeles, California, USA PubMed articlesGoogle scholar articles; Pengchao Li Department of Urology, the First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital), Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Fan Huo State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Ru Jia State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Zhu A Wang Department of Molecular Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, USA PubMed articlesGoogle scholar articles; Qiang Lv Department of Urology, the First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital), Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles; Chao Yan State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, ChinaEngineering Research Center of Protein and Peptide Medicine, Ministry of Education, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003939
14,Original research: Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer,"Katy McCann, Adrian von Witzleben, Jaya Thomas, Chuan Wang, Oliver Wood, Divya Singh, Konstantinos Boukas, Kaidre Bendjama, Nathalie Silvestre, Finn Cilius Nielsen, Gareth Thomas, Tilman Sanchez-Elsner, Jason Greenbaum, Stephen Schoenberger, Bjoern Peters, Pandurangan Vijayanand, Natalia Savelyeva, Christian Ottensmeier","Katy McCann Cancer Research UK Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, UK PubMed articlesGoogle scholar articles; Jaya Thomas Cancer Research UK Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, UK PubMed articlesGoogle scholar articles; Oliver Wood Cancer Research UK Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, UK PubMed articlesGoogle scholar articles; Konstantinos Boukas Cancer Research UK Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, UK PubMed articlesGoogle scholar articles; Nathalie Silvestre Research and Development Department, Transgene, Illkirch-Graffenstaden, France PubMed articlesGoogle scholar articles; Gareth Thomas Cancer Research UK Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, UKUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK PubMed articlesGoogle scholar articles; Jason Greenbaum Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA PubMed articlesGoogle scholar articles; Bjoern Peters Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA PubMed articlesGoogle scholar articles; Natalia Savelyeva Head and Neck Centre, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles; Adrian von Witzleben Cancer Research UK Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, UKDepartment of Otorhinolaryngology, Head & Neck Surgery, University of Ulm, Ulm, Germany PubMed articlesGoogle scholar articles; Chuan Wang Head and Neck Centre, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles; Divya Singh Cancer Research UK Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, UK PubMed articlesGoogle scholar articles; Kaidre Bendjama Research and Development Department, Transgene, Illkirch-Graffenstaden, France PubMed articlesGoogle scholar articles; Finn Cilius Nielsen Center for Genomic Medicine, Rigshospitalet, Kobenhavn, Denmark PubMed articlesGoogle scholar articles; Tilman Sanchez-Elsner Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK PubMed articlesGoogle scholar articles; Stephen Schoenberger Laboratory of Cellular Immunology, La Jolla Institute for Immunology, La Jolla, California, USA PubMed articlesGoogle scholar articles; Pandurangan Vijayanand La Jolla Institute for Immunology, La Jolla, California, USA PubMed articlesGoogle scholar articles; Christian Ottensmeier Cancer Research UK Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, UKHead and Neck Centre, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UKLa Jolla Institute for Immunology, La Jolla, California, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003821
15,Original research: Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy,"Megan L Baker, Yu Yamamoto, Mark A Perazella, Nazli Dizman, Anushree C Shirali, Navid Hafez, Jason Weinstein, Michael Simonov, Jeffrey M Testani, Harriet M Kluger, Lloyd G Cantley, Chirag R Parikh, F Perry Wilson, Dennis G Moledina","Megan L Baker Section of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles; Mark A Perazella Section of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles; Anushree C Shirali Section of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles; Jason Weinstein Section of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USAClinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles; Jeffrey M Testani Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles; Lloyd G Cantley Section of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles; F Perry Wilson Section of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USAClinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles; Yu Yamamoto Section of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USAClinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles; Nazli Dizman Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA PubMed articlesGoogle scholar articles; Navid Hafez Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles; Michael Simonov Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles; Harriet M Kluger Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles; Chirag R Parikh Division of Nephrology, Johns Hopkins University, Baltimore, MD, USA PubMed articlesGoogle scholar articles; Dennis G Moledina Section of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USAClinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004421
16,"Original research: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma","Jun Liu, Yang Yang, Zhichao Liu, Xiaolong Fu, Xiaoyue Cai, Hongxuan Li, Li Zhu, Yan Shen, Hong Zhang, Yifeng Sun, Hezhong Chen, Bentong Yu, Renquan Zhang, Jinchen Shao, Ming Zhang, Zhigang Li","Jun Liu Department of Radiation Oncology, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Zhichao Liu Department of Thoracic Surgery, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Xiaoyue Cai Department of Integrative Medicine, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Li Zhu Department of Radiology, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Hong Zhang Department of Thoracic Surgery, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Hezhong Chen Department of Thoracic Surgery, Changhai Hospital, Shanghai, China PubMed articlesGoogle scholar articles; Renquan Zhang Department of Thoracic Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China PubMed articlesGoogle scholar articles; Ming Zhang Department of Integrative Medicine, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Yang Yang Department of Thoracic Surgery, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Xiaolong Fu Department of Radiation Oncology, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Hongxuan Li Department of Radiation Oncology, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Yan Shen Department of Radiology, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Yifeng Sun Department of Thoracic Surgery, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Bentong Yu Department of Thoracic Surgery, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China PubMed articlesGoogle scholar articles; Jinchen Shao Department of Pathology, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles; Zhigang Li Department of Thoracic Surgery, Shanghai Jiao Tong University, Shanghai, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004291
17,"Original research: IOLite: phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin–paclitaxel, with or without bevacizumab in patients with advanced cancer","Timothy A Yap, Alberto Bessudo, Erika Hamilton, Jasgit Sachdev, Manish R Patel, Jordi Rodon, Lena Evilevitch, Meghan Duncan, Wei Guo, Sujatha Kumar, Sharon Lu, Bruce J Dezube, Nashat Gabrail","Timothy A Yap Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Erika Hamilton Sara Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, USA PubMed articlesGoogle scholar articles; Manish R Patel Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida, USA PubMed articlesGoogle scholar articles; Lena Evilevitch GlaxoSmithKline, Waltham, Massachusetts, USA PubMed articlesGoogle scholar articles; Wei Guo GlaxoSmithKline, Waltham, Massachusetts, USA PubMed articlesGoogle scholar articles; Sharon Lu GlaxoSmithKline, Waltham, Massachusetts, USA PubMed articlesGoogle scholar articles; Nashat Gabrail Department of Oncology, Gabrail Cancer Center, Canton, Ohio, USA PubMed articlesGoogle scholar articles; Alberto Bessudo California Cancer Associates for Research and Excellence, San Diego, California, USA PubMed articlesGoogle scholar articles; Jasgit Sachdev HonorHealth Research Institute/TGen, Scottsdale, Arizona, USA PubMed articlesGoogle scholar articles; Jordi Rodon Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; Meghan Duncan Xilio Therapeutics, Waltham, Massachusetts, USA PubMed articlesGoogle scholar articles; Sujatha Kumar GlaxoSmithKline, Waltham, Massachusetts, USA PubMed articlesGoogle scholar articles; Bruce J Dezube GlaxoSmithKline, Waltham, Massachusetts, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003924
18,"Original research: 1α,25(OH)2D3 reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells","Peng Li, Xinhai Zhu, Guangchao Cao, Ruan Wu, Ke Li, Wenhui Yuan, Biyun Chen, Guodong Sun, Xichun Xia, Hua Zhang, Xiao Wang, Zhinan Yin, Ligong Lu, Yunfei Gao","Peng Li Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, Guangdong, ChinaThe Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Guangchao Cao Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, Guangdong, ChinaThe Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Ke Li Department of Infectious Disease, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Biyun Chen Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Xichun Xia Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, Guangdong, ChinaThe Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Xiao Wang Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, Guangdong, ChinaThe Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Ligong Lu Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, Guangdong, China PubMed articlesGoogle scholar articles; Xinhai Zhu Department of Oncology, First Affiliated Hospital, Jinan University, Jinan University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Ruan Wu Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China PubMed articlesGoogle scholar articles; Wenhui Yuan Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, Guangdong, ChinaThe Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Guodong Sun Department of Orthopedics, First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Hua Zhang Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, Guangdong, ChinaThe Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Zhinan Yin Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, Guangdong, ChinaThe Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Yunfei Gao Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, Guangdong, ChinaThe Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003477
19,Original research: Harnessing radiotherapy-induced NK-cell activity by combining DNA damage–response inhibition and immune checkpoint blockade,"Emmanuel C Patin, Magnus T Dillon, Pablo Nenclares, Lorna Grove, Heba Soliman, Isla Leslie, Davina Northcote, Galabina Bozhanova, Eva Crespo-Rodriguez, Holly Baldock, Harriet Whittock, Gabriella Baker, Joan Kyula, Jeane Guevara, Alan A Melcher, James Harper, Hormas Ghadially, Simon Smith, Malin Pedersen, Martin McLaughlin, Kevin J Harrington","Emmanuel C Patin Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Pablo Nenclares Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKHead and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK PubMed articlesGoogle scholar articles; Heba Soliman Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK PubMed articlesGoogle scholar articles; Davina Northcote Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK PubMed articlesGoogle scholar articles; Eva Crespo-Rodriguez Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Harriet Whittock Biological Services Unit, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Joan Kyula Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Alan A Melcher Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Hormas Ghadially Early Oncology R&D, AstraZeneca, Cambridge, UK PubMed articlesGoogle scholar articles; Malin Pedersen Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Kevin J Harrington Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKHead and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK PubMed articlesGoogle scholar articles; Magnus T Dillon Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Lorna Grove Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKHead and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK PubMed articlesGoogle scholar articles; Isla Leslie Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK PubMed articlesGoogle scholar articles; Galabina Bozhanova Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Holly Baldock Biological Services Unit, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Gabriella Baker Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Jeane Guevara Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK PubMed articlesGoogle scholar articles; James Harper Early Oncology R&D, AstraZeneca, Cambridge, UK PubMed articlesGoogle scholar articles; Simon Smith Early Oncology R&D, AstraZeneca, Cambridge, UK PubMed articlesGoogle scholar articles; Martin McLaughlin Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004306
20,Original research: Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway,"Ye Shen, Jason S Eng, Flordeliza Fajardo, Lingming Liang, Cong Li, Patrick Collins, Donato Tedesco, Olivier Nolan-Stevaux","Ye Shen Oncology Research, Amgen Inc, South San Francisco, California, USA PubMed articlesGoogle scholar articles; Flordeliza Fajardo Oncology Research, Amgen Inc, South San Francisco, California, USA PubMed articlesGoogle scholar articles; Cong Li Oncology Research, Amgen Inc, South San Francisco, California, USA PubMed articlesGoogle scholar articles; Donato Tedesco Cellecta Inc, Mountain View, California, USA PubMed articlesGoogle scholar articles; Jason S Eng Oncology Research, Amgen Inc, South San Francisco, California, USA PubMed articlesGoogle scholar articles; Lingming Liang Oncology Research, Amgen Inc, South San Francisco, California, USA PubMed articlesGoogle scholar articles; Patrick Collins Genome Analysis Unit, Amgen Inc, South San Francisco, California, USA PubMed articlesGoogle scholar articles; Olivier Nolan-Stevaux Oncology Research, Amgen Inc, South San Francisco, California, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004348
21,Original research: Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer,"Safae Terrisse, Anne-Gaelle Goubet, Kousuke Ueda, Andrew Maltez Thomas, Valentin Quiniou, Cassandra Thelemaque, Garett Dunsmore, Emmanuel Clave, Melissa Gamat-Huber, Satoru Yonekura, Gladys Ferrere, Conrad Rauber, Hang Phuong Pham, Jean-Eudes Fahrner, Eugenie Pizzato, Pierre Ly, Marine Fidelle, Marine Mazzenga, Carolina Alves Costa Silva, Federica Armanini, Federica Pinto, Francesco Asnicar, Romain Daillère, Lisa Derosa, Corentin Richard, Pierre Blanchard, Bertrand Routy, Stéphane Culine, Paule Opolon, Aymeric Silvin, Florent Ginhoux, Antoine Toubert, Nicola Segata, Douglas G McNeel, Karim Fizazi, Guido Kroemer, Laurence Zitvogel","Safae Terrisse INSERM U1015, Gustave Roussy, Villejuif, FranceMedical Oncology, Hôpital Saint-Louis, Paris, France PubMed articlesGoogle scholar articles; Kousuke Ueda Department of Urology, Kurume University School of Medicine, Kurume, Japan PubMed articlesGoogle scholar articles; Valentin Quiniou Parean Biotechnologies, Saint Malo, France PubMed articlesGoogle scholar articles; Garett Dunsmore INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Melissa Gamat-Huber UW Carbone Cancer Center, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles; Gladys Ferrere INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Hang Phuong Pham Parean Biotechnologies, Saint Malo, France PubMed articlesGoogle scholar articles; Eugenie Pizzato INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Marine Fidelle INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Carolina Alves Costa Silva INSERM U1015, Gustave Roussy, Villejuif, FranceUniversité Paris-Saclay, Saint-Aubin, France PubMed articlesGoogle scholar articles; Federica Pinto Department CIBIO, University of Trento, Trento, Italy PubMed articlesGoogle scholar articles; Romain Daillère Gustave Roussy, Villejuif, FranceEverImmune Gustave Roussy Cancer Center, Villejuif, France PubMed articlesGoogle scholar articles; Corentin Richard Département de Médicine, CHUM, Montreal, Québec, Canada PubMed articlesGoogle scholar articles; Bertrand Routy Département de Médicine, CHUM, Montreal, Québec, CanadaCRCHUM, Montreal, Québec, Canada PubMed articlesGoogle scholar articles; Paule Opolon Department of Biology and Medical Pathology, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Florent Ginhoux INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Nicola Segata Department CIBIO, University of Trento, Trento, Italy PubMed articlesGoogle scholar articles; Karim Fizazi Université Paris-Saclay, Saint-Aubin, FranceDepartment of Medical Oncology, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Laurence Zitvogel Gustave Roussy Cancer Campus, Villejuif, FranceUniversité Paris-Saclay Faculté de Médecine, Le Kremlin-Bicetre, France PubMed articlesGoogle scholar articles; Anne-Gaelle Goubet INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Andrew Maltez Thomas Department CIBIO, University of Trento, Trento, Italy PubMed articlesGoogle scholar articles; Cassandra Thelemaque INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Emmanuel Clave Institut de Recherche de Paris, INSERM UMRS-1160, Université de Paris, Paris, France PubMed articlesGoogle scholar articles; Satoru Yonekura INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Conrad Rauber INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Jean-Eudes Fahrner INSERM U1015, Gustave Roussy, Villejuif, FranceUniversité Paris-Saclay, Saint-Aubin, France PubMed articlesGoogle scholar articles; Pierre Ly INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Marine Mazzenga INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Federica Armanini Department CIBIO, University of Trento, Trento, Italy PubMed articlesGoogle scholar articles; Francesco Asnicar Department CIBIO, University of Trento, Trento, Italy PubMed articlesGoogle scholar articles; Lisa Derosa INSERM U1015, Gustave Roussy, Villejuif, FranceCenter of Clinical Investistigations in Biotherapies of Cancer (CICBT), Villejuif, France PubMed articlesGoogle scholar articles; Pierre Blanchard Department of Radiation Oncology, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Stéphane Culine Medical Oncology, Hôpital Saint-Louis, Paris, FranceUniversité de Paris, Paris, France PubMed articlesGoogle scholar articles; Aymeric Silvin INSERM U1015, Gustave Roussy, Villejuif, France PubMed articlesGoogle scholar articles; Antoine Toubert Institut de Recherche Saint Louis, INSERM U1160, Université de Paris, Paris, FranceLaboratoire d'immunologie et d'histocompatibilité, Hôpital Saint-Louis, Paris, France PubMed articlesGoogle scholar articles; Douglas G McNeel Medicine, University of Wisconsin Madison, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles; Guido Kroemer Gustave Roussy, Villejuif, FranceSorbonne Université INSERM U1138, Université de Paris, Paris, France PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004191
22,Original research: MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer,"Manu Prasad, Jonathan Zorea, Sankar Jagadeeshan, Avital B Shnerb, Sooraj Mathukkada, Jebrane Bouaoud, Lucas Michon, Ofra Novoplansky, Mai Badarni, Limor Cohen, Ksenia M Yegodayev, Sapir Tzadok, Barak Rotblat, Libor Brezina, Andreas Mock, Andy Karabajakian, Jérôme Fayette, Idan Cohen, Tomer Cooks, Irit Allon, Orr Dimitstein, Benzion Joshua, Dexin Kong, Elena Voronov, Maurizio Scaltriti, Yaron Carmi, Cristina Conde-Lopez, Jochen Hess, Ina Kurth, Luc G T Morris, Pierre Saintigny, Moshe Elkabets","Manu Prasad The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Sankar Jagadeeshan The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Sooraj Mathukkada The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Lucas Michon Univ Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69373, France PubMed articlesGoogle scholar articles; Mai Badarni The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Ksenia M Yegodayev The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Barak Rotblat Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Andreas Mock Department of Medical Oncology, Heidelberg University Hospital, Heidelberg, GermanyDivision of Translational Medical Oncology, NCT Heidelberg, German Cancer Research Centre (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles; Jérôme Fayette Department of Translational Medicine Oncology, Centre Léon Bérard, Lyon 69373, FranceUniv Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69373, FranceDepartment of Medical Oncology, Centre Léon Bérard, Lyon 69373, France PubMed articlesGoogle scholar articles; Tomer Cooks The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Orr Dimitstein Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, IsraelDepartment of Otolaryngology-Head & Neck Surgery, Soroka University Medical Center, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Dexin Kong School of Pharmaceutical Sciences, Tianjin Medical University, Tianjin, China PubMed articlesGoogle scholar articles; Maurizio Scaltriti Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York City, New York, USA PubMed articlesGoogle scholar articles; Cristina Conde-Lopez Division of Radiooncology-Radiobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles; Ina Kurth Division of Radiooncology-Radiobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles; Pierre Saintigny Department of Translational Medicine Oncology, Centre Léon Bérard, Lyon 69373, FranceUniv Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69373, FranceDepartment of Medical Oncology, Centre Léon Bérard, Lyon 69373, France PubMed articlesGoogle scholar articles; Jonathan Zorea The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Avital B Shnerb The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Jebrane Bouaoud Department of Translational Medicine Oncology, Centre Léon Bérard, Lyon 69373, FranceUniv Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69373, France PubMed articlesGoogle scholar articles; Ofra Novoplansky The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Limor Cohen The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Sapir Tzadok The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Libor Brezina The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Andy Karabajakian Department of Translational Medicine Oncology, Centre Léon Bérard, Lyon 69373, FranceUniv Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69373, FranceDepartment of Medical Oncology, Centre Léon Bérard, Lyon 69373, France PubMed articlesGoogle scholar articles; Idan Cohen The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Irit Allon Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, IsraelInstitute of Pathology, Barzilai University Medical Center, Ashkelon, Israel PubMed articlesGoogle scholar articles; Benzion Joshua Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, IsraelDepartment of Otorhinolaryngology and Head & Neck Surgery, Barzilai Medical Center, Ashkelon, Israel PubMed articlesGoogle scholar articles; Elena Voronov The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles; Yaron Carmi Department of Pathology, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles; Jochen Hess Section Experimental and Translational Head and Neck Oncology, Department of Otolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, GermanyResearch Group Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles; Luc G T Morris Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles; Moshe Elkabets The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, IsraelFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003917
23,The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation,"Eva Sum, Moritz Rapp, Harald Dürr, Alekhya Mazumdar, Pedro J Romero, Christine Trumpfheller, Pablo Umaña","Eva Sum Cancer Immunotherapy, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland PubMed articlesGoogle scholar articles; Harald Dürr Large Molecule Research, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany PubMed articlesGoogle scholar articles; Pedro J Romero Oncology, University of Lausanne, Epalinges, Switzerland PubMed articlesGoogle scholar articles; Pablo Umaña Cancer Immunotherapy, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland PubMed articlesGoogle scholar articles; Moritz Rapp Cancer Immunotherapy, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany PubMed articlesGoogle scholar articles; Alekhya Mazumdar Urology, UniversitätsSpital Zürich, Schlieren, Switzerland PubMed articlesGoogle scholar articles; Christine Trumpfheller Cancer Immunotherapy, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003264
24,"Original research: Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer","Stephanie Lheureux, Daniela E Matei, Panagiotis A Konstantinopoulos, Ben X Wang, Ramy Gadalla, Matthew S Block, Andrea Jewell, Stephanie L Gaillard, Michael McHale, Carolyn McCourt, Sarah Temkin, Eugenia Girda, Floor J Backes, Theresa L Werner, Linda Duska, Siobhan Kehoe, Ilaria Colombo, Lisa Wang, Xuan Li, Rachel Wildman, Shirin Soleimani, Scott Lien, John Wright, Trevor Pugh, Pamela S Ohashi, David G Brooks, Gini F Fleming","Stephanie Lheureux Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; Panagiotis A Konstantinopoulos Department of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Ramy Gadalla Immune Profiling Team – Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; Andrea Jewell Department of Gynecologic Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA PubMed articlesGoogle scholar articles; Michael McHale Department of Obstetrics and Gynecology, Moores Cancer Centre, UC San Diego Health, La Jolla, California, USA PubMed articlesGoogle scholar articles; Sarah Temkin Department of Gynecology Oncology, Virginia Commonwealth University, Richmond, Virginia, USA PubMed articlesGoogle scholar articles; Floor J Backes Department of Gynecologic Oncology, Ohio State University, Columbus, Ohio, USA PubMed articlesGoogle scholar articles; Linda Duska Department of Gynecology Oncology, University of Virginia, Charlottesville, Virginia, USA PubMed articlesGoogle scholar articles; Ilaria Colombo Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; Xuan Li Department of Statistics, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; Shirin Soleimani Department of Medical Biophysics, University of Toronto, Toronto, Ontario, CanadaCancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; John Wright Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles; Pamela S Ohashi Department of Immunology, University of Toronto, Toronto, Ontario, CanadaDepartment of Immunology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; Gini F Fleming Department of Medicine, University of Chicago Medicine, Chicago, Illinois, USA PubMed articlesGoogle scholar articles; Daniela E Matei Department of Obstetrics and Gynecology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Illinois, USA PubMed articlesGoogle scholar articles; Ben X Wang Immune Profiling Team – Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; Matthew S Block Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles; Stephanie L Gaillard Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles; Carolyn McCourt Department of Gynecology Oncology, Washington University School of Medicine, St Louis, Missouri, USA PubMed articlesGoogle scholar articles; Eugenia Girda Department of Gynecology Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA PubMed articlesGoogle scholar articles; Theresa L Werner Division of Oncology, Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA PubMed articlesGoogle scholar articles; Siobhan Kehoe Department of Gynecology Oncology, NYU Langone, New York City, New York, USA PubMed articlesGoogle scholar articles; Lisa Wang Department of Statistics, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; Rachel Wildman Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; Scott Lien Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, CanadaDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; Trevor Pugh Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; David G Brooks Department of Immunology, University of Toronto, Toronto, Ontario, CanadaDepartment of Immunology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004233
25,"Original research: Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study","Aung Naing, John D Powderly, John J Nemunaitis, Jason J Luke, Aaron S Mansfield, Wells A Messersmith, Solmaz Sahebjam, Patricia M LoRusso, Ignacio Garrido-Laguna, Lance Leopold, Ryan Geschwindt, Kai Ding, Michael Smith, Jordan D Berlin","Aung Naing Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles; John J Nemunaitis University of Toledo College of Medicine, Toledo, Ohio, USA PubMed articlesGoogle scholar articles; Aaron S Mansfield Oncology, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles; Solmaz Sahebjam Clinical Research Unit, Moffitt Cancer Center, Tampa, Florida, USA PubMed articlesGoogle scholar articles; Ignacio Garrido-Laguna University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA PubMed articlesGoogle scholar articles; Ryan Geschwindt Immuno-Oncology, Incyte Corporation, Wilmington, Delaware, USA PubMed articlesGoogle scholar articles; Michael Smith Immuno-Oncology, Incyte Corporation, Wilmington, Delaware, USA PubMed articlesGoogle scholar articles; John D Powderly Cancer Research Clinic, Carolina Biooncology Institute, Huntersville, North Carolina, USA PubMed articlesGoogle scholar articles; Jason J Luke Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA PubMed articlesGoogle scholar articles; Wells A Messersmith School of Medicine, University of Colorado, Aurora, Colorado, USA PubMed articlesGoogle scholar articles; Patricia M LoRusso Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut, USA PubMed articlesGoogle scholar articles; Lance Leopold Immuno-Oncology, Incyte Corporation, Wilmington, Delaware, USA PubMed articlesGoogle scholar articles; Kai Ding Biostatistics, Incyte Corporation, Wilmington, Delaware, USA PubMed articlesGoogle scholar articles; Jordan D Berlin Division of Hematology/Oncology, Vanderbilt University, Nashville, Tennessee, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004223
26,Original research: A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL,"Naveen K Mehta, Martin Pfluegler, Kristan Meetze, Bochong Li, Isabelle Sindel, Fabian Vogt, Melanie Marklin, Jonas S Heitmann, Joseph Kauer, Lukas Osburg, Latifa Zekri, Hans-Jörg Bühring, Stefanie Mueller, Sebastian Hörner, Patrick A Baeuerle, Jennifer S Michaelson, Gundram Jung, Helmut R Salih","Naveen K Mehta Cullinan Florentine Corp, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles; Kristan Meetze Cullinan Florentine Corp, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles; Isabelle Sindel Immunology, Eberhard Karls Universitat Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Melanie Marklin Clinical Collaboration Unit Translational Immunology, University Hospitals Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Joseph Kauer Immunology, Eberhard Karls Universitat Tubingen, Tubingen, GermanyClinical Collaboration Unit Translational Immunology, University Hospitals Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Latifa Zekri Immunology, Eberhard Karls Universitat Tubingen, Tubingen, GermanyClinical Collaboration Unit Translational Immunology, University Hospitals Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Stefanie Mueller Clinical Collaboration Unit Translational Immunology, University Hospitals Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Patrick A Baeuerle Cullinan Florentine Corp, Cambridge, Massachusetts, USAImmunology, Ludwig-Maximilians-Universitat Munchen, Munchen, Germany PubMed articlesGoogle scholar articles; Gundram Jung Immunology, Eberhard Karls Universitat Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Martin Pfluegler Immunology, Eberhard Karls Universitat Tubingen, Tubingen, GermanyClinical Collaboration Unit Translational Immunology, University Hospitals Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Bochong Li Cullinan Florentine Corp, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles; Fabian Vogt Immunology, Eberhard Karls Universitat Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Jonas S Heitmann Clinical Collaboration Unit Translational Immunology, University Hospitals Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Lukas Osburg Immunology, Eberhard Karls Universitat Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Hans-Jörg Bühring Internal Medicine, Eberhard Karls Universitat Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Sebastian Hörner Immunology, Eberhard Karls Universitat Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles; Jennifer S Michaelson Cullinan Florentine Corp, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles; Helmut R Salih Clinical Collaboration Unit Translational Immunology, University Hospitals Tubingen, Tubingen, GermanyImage-Guided and Functional Instructed Tumor Therapy, Eberhard Karls Universitat Tubingen, Tubingen, Germany PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003882
27,Original research: Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer,"Yumeng Wang, Congwen Wang, Junjun Qiu, Xinyu Qu, Jing Peng, Chong Lu, Meng Zhang, Mingxing Zhang, Xingling Qi, Guiling Li, Keqin Hua","Yumeng Wang Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaShanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Junjun Qiu Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaShanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Jing Peng Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaDepartment of Integration of Western and Traditional Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Meng Zhang Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaDepartment of Integration of Western and Traditional Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Xingling Qi Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaDepartment of Integration of Western and Traditional Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Keqin Hua Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaShanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Congwen Wang Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaDepartment of Integration of Western and Traditional Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Xinyu Qu Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaShanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Chong Lu Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaDepartment of Integration of Western and Traditional Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Mingxing Zhang Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaDepartment of Integration of Western and Traditional Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Guiling Li Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaDepartment of Integration of Western and Traditional Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003667
28,"Original research: Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)","Douglas G McNeel, Jens C Eickhoff, Ellen Wargowski, Laura E Johnson, Christos E Kyriakopoulos, Hamid Emamekhoo, Joshua M Lang, Mary Jane Brennan, Glenn Liu","Douglas G McNeel Department of Medicine, Carbone Cancer Center, University of Wisconsin—Madison, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles; Ellen Wargowski Department of Medicine, Carbone Cancer Center, University of Wisconsin—Madison, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles; Christos E Kyriakopoulos Department of Medicine, Carbone Cancer Center, University of Wisconsin—Madison, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles; Joshua M Lang Department of Medicine, Carbone Cancer Center, University of Wisconsin—Madison, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles; Glenn Liu Department of Medicine, Carbone Cancer Center, University of Wisconsin—Madison, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles; Jens C Eickhoff Department of Biostatistics and Medical Informatics, University of Wisconsin—Madison, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles; Laura E Johnson Department of Medicine, Carbone Cancer Center, University of Wisconsin—Madison, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles; Hamid Emamekhoo Department of Medicine, Carbone Cancer Center, University of Wisconsin—Madison, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles; Mary Jane Brennan Department of Medicine, Carbone Cancer Center, University of Wisconsin—Madison, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004198
29,"Original research: The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signaling","Max O Meneveau, Pankaj Kumar, Kevin T Lynch, Sapna P Patel, Craig L Slingluff","Max O Meneveau Department of Surgery, University of Virginia, Charlottesville, Virginia, USA PubMed articlesGoogle scholar articles; Kevin T Lynch Department of Surgery, University of Virginia, Charlottesville, Virginia, USA PubMed articlesGoogle scholar articles; Craig L Slingluff Department of Surgery, University of Virginia, Charlottesville, Virginia, USAUniversity of Virginia Cancer Center, Charlottesville, Virginia, USA PubMed articlesGoogle scholar articles; Pankaj Kumar Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia, USA PubMed articlesGoogle scholar articles; Sapna P Patel Department of Melanoma/Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003533
30,Original research: CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype,"Han Li, Fan Luo, Xingyu Jiang, Weijing Zhang, Tong Xiang, Qiuzhong Pan, Liming Cai, Jingjing Zhao, Desheng Weng, Yue Li, Yuhu Dai, Fengze Sun, Chaopin Yang, Yue Huang, Jieying Yang, Yan Tang, Yulong Han, Mian He, Yanna Zhang, Libing Song, Jian-Chuan Xia","Han Li Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Gynecology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Xingyu Jiang Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles; Tong Xiang Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Liming Cai Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China PubMed articlesGoogle scholar articles; Desheng Weng Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Yuhu Dai Department of Orthopaedic Surgery, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Chaopin Yang Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Jieying Yang Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Yulong Han Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Yanna Zhang Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles; Jian-Chuan Xia Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Fan Luo Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles; Weijing Zhang Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles; Qiuzhong Pan Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Jingjing Zhao Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Yue Li Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles; Fengze Sun Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Yue Huang Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Yan Tang Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Mian He Department of Gynecology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles; Libing Song Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004029
31,Original research: Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors,"Osama E Rahma, Kevin Tyan, Anita Giobbie-Hurder, Andrew S Brohl, Philippe L Bedard, Daniel J Renouf, Elad Sharon, Howard Streicher, Emma Hathaway, Rachel Cunningham, Michael Manos, Mariano Severgnini, Scott Rodig, F Stephen Hodi","Osama E Rahma Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USAHarvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Anita Giobbie-Hurder Division of Biostatistics, Department of Data Sciences, Dana Farber Cancer Institute, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Philippe L Bedard Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; Elad Sharon Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles; Emma Hathaway Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USACenter for Immuno-Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Michael Manos Center for Immuno-Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Scott Rodig Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Kevin Tyan Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Andrew S Brohl Sarcoma Department and Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA PubMed articlesGoogle scholar articles; Daniel J Renouf Cancer and Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles; Howard Streicher Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles; Rachel Cunningham Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USACenter for Immuno-Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Mariano Severgnini Center for Immuno-Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; F Stephen Hodi Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USAHarvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003569
32,Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy,"Katie M Campbell, Maneesha Thaker, Egmidio Medina, Anusha Kalbasi, Arun Singh, Antoni Ribas, Theodore Scott Nowicki","Katie M Campbell 
Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, USA
 PubMed articlesGoogle scholar articles; Egmidio Medina 
Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, USA
 PubMed articlesGoogle scholar articles; Arun Singh 
Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, USA
 PubMed articlesGoogle scholar articles; Theodore Scott Nowicki 
Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, USA

Pediatrics, Division of Pediatric Hematology/Oncology, University of California, Los Angeles, Los Angeles, California, USA

Microbiology, Immunology, & Molecular Genetics, University of California, Los Angeles, Los Angeles, California, USA

Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, California, USA
 PubMed articlesGoogle scholar articles; Maneesha Thaker 
Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, USA

Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California, USA
 PubMed articlesGoogle scholar articles; Anusha Kalbasi 
Radiation Oncology, University of California, Los Angeles, Los Angeles, California, USA

Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, USA
 PubMed articlesGoogle scholar articles; Antoni Ribas 
Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, USA

Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California, USA

Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, USA

Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, California, USA

Parker Institute for Cancer Immunotherapy, San Francisco, California, USA
 PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004190
33,Original research: Preclinical characterization of the novel anti-SIRPα antibody BR105 that targets the myeloid immune checkpoint,"Zhen-Hua Wu, Na Li, Xiao-Feng Mei, Juan Chen, Xiao-Ze Wang, Ting-Ting Guo, Gang Chen, Lei Nie, Yao Chen, Mei-Zhu Jiang, Ji-Teng Wang, Hai-Bin Wang","Zhen-Hua Wu BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China PubMed articlesGoogle scholar articles; Xiao-Feng Mei BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China PubMed articlesGoogle scholar articles; Xiao-Ze Wang BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China PubMed articlesGoogle scholar articles; Gang Chen BioRay Pharmaceutical Corp, San Diego, California, USA PubMed articlesGoogle scholar articles; Yao Chen BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China PubMed articlesGoogle scholar articles; Ji-Teng Wang BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China PubMed articlesGoogle scholar articles; Na Li BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China PubMed articlesGoogle scholar articles; Juan Chen BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China PubMed articlesGoogle scholar articles; Ting-Ting Guo BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China PubMed articlesGoogle scholar articles; Lei Nie BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China PubMed articlesGoogle scholar articles; Mei-Zhu Jiang BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China PubMed articlesGoogle scholar articles; Hai-Bin Wang BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004054
34,"Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study","Haiping Jiang, Xiongfei Yu, Ning Li, Mei Kong, Zhimin Ma, Donghui Zhou, Weibin Wang, Haohao Wang, Haiyong Wang, Kuifeng He, Zhongqi Li, Yimin Lu, Jing Zhang, Kui Zhao, Yafei Zhang, Nong Xu, Ziran Li, Ying Liu, Yan Wang, Yisen Wang, Lisong Teng","Haiping Jiang Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Ning Li Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Zhimin Ma Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Weibin Wang Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Haiyong Wang Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Zhongqi Li Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Jing Zhang Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Yafei Zhang Department of Nuclear Medicine, PET Centre, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Ziran Li Department of Medical Science and Strategy Oncology, Innovent Biologics, Inc, Suzhou, China PubMed articlesGoogle scholar articles; Yan Wang Department of Medical Science and Strategy Oncology, Innovent Biologics, Inc, Suzhou, China PubMed articlesGoogle scholar articles; Lisong Teng Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Xiongfei Yu Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Mei Kong Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Donghui Zhou Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Haohao Wang Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Kuifeng He Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Yimin Lu Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Kui Zhao Department of Nuclear Medicine, PET Centre, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Nong Xu Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China PubMed articlesGoogle scholar articles; Ying Liu Department of Medical Science and Strategy Oncology, Innovent Biologics, Inc, Suzhou, China PubMed articlesGoogle scholar articles; Yisen Wang Department of Translational Medicine, Innovent Biologics, Inc, Suzhou, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003635
35,Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study,"Qi Mei, Guangyuan Hu, Yang Yang, Bo Liu, Junping Yin, Ming Li, Qiao Huang, Xi Tang, Alexander Böhner, Amy Bryant, Christian Kurts, Xianglin Yuan, Jian Li","Qi Mei Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China PubMed articlesGoogle scholar articles; Yang Yang Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China PubMed articlesGoogle scholar articles; Junping Yin Institute of Molecular Medicine and Experimental Immunology, University Clinic of Rheinische Friedrich-Wilhelms-University, Bonn, Germany PubMed articlesGoogle scholar articles; Qiao Huang Department of Oncology, The First College of Clinical Medical Science, Yichang, Hubei, China PubMed articlesGoogle scholar articles; Alexander Böhner Institute of Molecular Medicine and Experimental Immunology, University Clinic of Rheinische Friedrich-Wilhelms-University, Bonn, Germany PubMed articlesGoogle scholar articles; Christian Kurts Institute of Molecular Medicine and Experimental Immunology, University Clinic of Rheinische Friedrich-Wilhelms-University, Bonn, Germany PubMed articlesGoogle scholar articles; Jian Li Institute of Molecular Medicine and Experimental Immunology, University Clinic of Rheinische Friedrich-Wilhelms-University, Bonn, Germany PubMed articlesGoogle scholar articles; Guangyuan Hu Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China PubMed articlesGoogle scholar articles; Bo Liu Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China PubMed articlesGoogle scholar articles; Ming Li Department of Oncology, Wuhan Pulmonary Hospital, Wuhan, Hubei, China PubMed articlesGoogle scholar articles; Xi Tang Department of Oncology, Jingzhou Central Hospital, Jingzhou, Hubei, China PubMed articlesGoogle scholar articles; Amy Bryant Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Meridian, Idaho, USA PubMed articlesGoogle scholar articles; Xianglin Yuan Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004157
36,Original research: Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis,"Xiaofang Xing, Jinyao Shi, Yongning Jia, Yunsheng Dou, Zhongwu Li, Bin Dong, Ting Guo, Xiaojing Cheng, Xiaomei Li, Hong Du, Ying Hu, Shuqin Jia, Jian Zhang, Ziyu Li, Jiafu Ji","Xiaofang Xing Department of Gastrointestinal Translational Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, China PubMed articlesGoogle scholar articles; Yongning Jia Department of Gastrointestinal Surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles; Zhongwu Li Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles; Ting Guo Department of Gastrointestinal Translational Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, China PubMed articlesGoogle scholar articles; Xiaomei Li Department of Gastrointestinal Translational Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, China PubMed articlesGoogle scholar articles; Ying Hu Biobank, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles; Jian Zhang Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China PubMed articlesGoogle scholar articles; Jiafu Ji Department of Gastrointestinal Translational Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, ChinaDepartment of Gastrointestinal Surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles; Jinyao Shi Department of Gastrointestinal Translational Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, ChinaDepartment of Gastrointestinal Surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles; Yunsheng Dou Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China PubMed articlesGoogle scholar articles; Bin Dong Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles; Xiaojing Cheng Department of Gastrointestinal Translational Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, China PubMed articlesGoogle scholar articles; Hong Du Department of Gastrointestinal Translational Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, China PubMed articlesGoogle scholar articles; Shuqin Jia Department of Molecular Diagnosis, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles; Ziyu Li Department of Gastrointestinal Surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003984
37,Original research: eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma,"Xisha Chen, Kuansong Wang, Shilong Jiang, Hongyin Sun, Xuanling Che, Minghui Zhang, Jiaying He, Ying Wen, Mengting Liao, Xiangling Li, Xiaoming Zhou, Jianxun Song, Xingcong Ren, Wenjun Yi, Jinming Yang, Xiang Chen, Mingzhu Yin, Yan Cheng","Xisha Chen Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, China PubMed articlesGoogle scholar articles; Shilong Jiang Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China PubMed articlesGoogle scholar articles; Xuanling Che Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China PubMed articlesGoogle scholar articles; Jiaying He Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China PubMed articlesGoogle scholar articles; Mengting Liao Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China PubMed articlesGoogle scholar articles; Xiaoming Zhou Department of Pharmacy, School of Medicine, Hunan Normal University, Changsha, China PubMed articlesGoogle scholar articles; Xingcong Ren Department of Cancer Biology and Toxicology, Department of Pharmacology, College of Medicine, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA PubMed articlesGoogle scholar articles; Jinming Yang Department of Cancer Biology and Toxicology, Department of Pharmacology, College of Medicine, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA PubMed articlesGoogle scholar articles; Mingzhu Yin Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China PubMed articlesGoogle scholar articles; Kuansong Wang Department of Pathology, Xiangya hospital and Department of Pathology, School of Basic Medicine, Central South University, Changsha, China PubMed articlesGoogle scholar articles; Hongyin Sun Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China PubMed articlesGoogle scholar articles; Minghui Zhang Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China PubMed articlesGoogle scholar articles; Ying Wen Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China PubMed articlesGoogle scholar articles; Xiangling Li Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, China PubMed articlesGoogle scholar articles; Jianxun Song Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, Texas, USA PubMed articlesGoogle scholar articles; Wenjun Yi Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China PubMed articlesGoogle scholar articles; Xiang Chen Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China PubMed articlesGoogle scholar articles; Yan Cheng Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004026
38,Original research: DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma,"Angelika Martina Starzer, Gerwin Heller, Erwin Tomasich, Thomas Melchardt, Katharina Feldmann, Teresa Hatziioannou, Stefan Traint, Christoph Minichsdorfer, Ursula Schwarz-Nemec, Maja Nackenhorst, Leonhard Müllauer, Matthias Preusser, Anna Sophie Berghoff, Thorsten Fuereder","Angelika Martina Starzer Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, AustriaDepartment of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Erwin Tomasich Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, AustriaDepartment of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Katharina Feldmann Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, AustriaDepartment of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Stefan Traint Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Ursula Schwarz-Nemec Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Leonhard Müllauer Department of Pathology, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Anna Sophie Berghoff Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, AustriaDepartment of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Gerwin Heller Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, AustriaDepartment of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Thomas Melchardt Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles; Teresa Hatziioannou Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, AustriaDepartment of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Christoph Minichsdorfer Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Maja Nackenhorst Department of Pathology, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Matthias Preusser Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, AustriaDepartment of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles; Thorsten Fuereder Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003420
39,Original research: Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer,"Yijia Xu, Han Zeng, Kaifeng Jin, Zhaopei Liu, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu","Yijia Xu Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Kaifeng Jin Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Yu Zhu Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China PubMed articlesGoogle scholar articles; Zewei Wang Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Jiejie Xu Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Han Zeng Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Zhaopei Liu Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles; Le Xu Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles; Yuan Chang Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003416
40,Original research: Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma,"Robert J Motzer, Toni K Choueiri, David F McDermott, Thomas Powles, Yann-Alexandre Vano, Saurabh Gupta, Jin Yao, Celine Han, Ron Ammar, Simon Papillon-Cavanagh, Shruti S Saggi, M Brent McHenry, Petra Ross-Macdonald, Megan Wind-Rotolo","Robert J Motzer Kidney Cancer Section, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles; David F McDermott Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Yann-Alexandre Vano Medical Oncology, Hôpital Européen Georges Pompidou, APHP-Centre, Université de Paris, Paris, FranceInflammation, Complement and Cancer, Centre de Recherche des Cordeliers, INSERM, Université de Paris, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles; Jin Yao Translational Medicine, Bristol Myers Squibb Co, Princeton, New Jersey, USA PubMed articlesGoogle scholar articles; Ron Ammar Translational Medicine, Bristol Myers Squibb Co, Princeton, New Jersey, USA PubMed articlesGoogle scholar articles; Shruti S Saggi Translational Medicine, Bristol Myers Squibb Co, Princeton, New Jersey, USA PubMed articlesGoogle scholar articles; Petra Ross-Macdonald Translational Medicine, Bristol Myers Squibb Co, Princeton, New Jersey, USA PubMed articlesGoogle scholar articles; Toni K Choueiri Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles; Thomas Powles Barts Cancer Centre, London, UK PubMed articlesGoogle scholar articles; Saurabh Gupta Translational Medicine, Bristol Myers Squibb Co, Princeton, New Jersey, USA PubMed articlesGoogle scholar articles; Celine Han Translational Medicine, Bristol Myers Squibb Co, Princeton, New Jersey, USA PubMed articlesGoogle scholar articles; Simon Papillon-Cavanagh Translational Medicine, Bristol Myers Squibb Co, Princeton, New Jersey, USA PubMed articlesGoogle scholar articles; M Brent McHenry Translational Medicine, Bristol Myers Squibb Co, Princeton, New Jersey, USA PubMed articlesGoogle scholar articles; Megan Wind-Rotolo Translational Medicine, Bristol Myers Squibb Co, Princeton, New Jersey, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004316
41,C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer,"Niklas Klümper, Jonas Saal, Fiamma Berner, Christa Lichtensteiger, Nina Wyss, Annkristin Heine, Franz Georg Bauernfeind, Jörg Ellinger, Peter Brossart, Stefan Diem, Sabine Schmid, Markus Joerger, Martin Frueh, Manuel Ritter, Michael Hölzel, Lukas Flatz, Tobias Bald","Niklas Klümper Institute for Experimental Oncology, University Hospital Bonn, Bonn, GermanyCenter for Integrated Oncology Cologne/Bonn, University Hospital Bonn, Bonn, GermanyDepartment of Urology, University Hospital Bonn, Bonn, Germany PubMed articlesGoogle scholar articles; Fiamma Berner Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland PubMed articlesGoogle scholar articles; Nina Wyss Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland PubMed articlesGoogle scholar articles; Franz Georg Bauernfeind Center for Integrated Oncology Cologne/Bonn, University Hospital Bonn, Bonn, GermanyMedical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany PubMed articlesGoogle scholar articles; Peter Brossart Center for Integrated Oncology Cologne/Bonn, University Hospital Bonn, Bonn, GermanyDepartment of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany PubMed articlesGoogle scholar articles; Sabine Schmid Department of Oncology and Hematology, Kantonsspital St Gallen, St Gallen, Switzerland PubMed articlesGoogle scholar articles; Martin Frueh Department of Oncology and Hematology, Kantonsspital St Gallen, St Gallen, SwitzerlandDepartment of Medical Oncology, University Hospital Bern, Bern, Switzerland PubMed articlesGoogle scholar articles; Michael Hölzel Institute for Experimental Oncology, University Hospital Bonn, Bonn, GermanyCenter for Integrated Oncology Cologne/Bonn, University Hospital Bonn, Bonn, Germany PubMed articlesGoogle scholar articles; Tobias Bald Institute for Experimental Oncology, University Hospital Bonn, Bonn, GermanyCenter for Integrated Oncology Cologne/Bonn, University Hospital Bonn, Bonn, Germany PubMed articlesGoogle scholar articles; Jonas Saal Center for Integrated Oncology Cologne/Bonn, University Hospital Bonn, Bonn, GermanyMedical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany PubMed articlesGoogle scholar articles; Christa Lichtensteiger Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland PubMed articlesGoogle scholar articles; Annkristin Heine Center for Integrated Oncology Cologne/Bonn, University Hospital Bonn, Bonn, GermanyMedical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany PubMed articlesGoogle scholar articles; Jörg Ellinger Center for Integrated Oncology Cologne/Bonn, University Hospital Bonn, Bonn, GermanyDepartment of Urology, University Hospital Bonn, Bonn, Germany PubMed articlesGoogle scholar articles; Stefan Diem Department of Oncology and Hematology, Kantonsspital St Gallen, St Gallen, Switzerland PubMed articlesGoogle scholar articles; Markus Joerger Department of Oncology and Hematology, Kantonsspital St Gallen, St Gallen, Switzerland PubMed articlesGoogle scholar articles; Manuel Ritter Center for Integrated Oncology Cologne/Bonn, University Hospital Bonn, Bonn, GermanyDepartment of Urology, University Hospital Bonn, Bonn, Germany PubMed articlesGoogle scholar articles; Lukas Flatz Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, SwitzerlandDepartment of Dermatology, Eberhard Karls University Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004024
42,Original research: MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer,"Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Coureche Kaderbhai, Romain Boidot, Sandy Chevrier, Philippe Joubert, Bertrand Routy, Caroline Truntzer, Francois Ghiringhelli","Julie Lecuelle Platform of Transfer in Biological Oncology, Georges-Francois Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, FranceUMR INSERM 1231, Dijon, Bourgogne-Franche-Comté, FranceGenomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, FranceUniversity of Burgundy-Franche Comté, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles; Cléa Fraisse Departmnt of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles; Coureche Kaderbhai Departmnt of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles; Sandy Chevrier Department of Biopathology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles; Bertrand Routy Department of Medicine Montréal, Division of Oncology, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, CanadaDivision of Hematology-Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Quebec City, Quebec, Canada PubMed articlesGoogle scholar articles; Francois Ghiringhelli Platform of Transfer in Biological Oncology, Georges-Francois Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, FranceUMR INSERM 1231, Dijon, Bourgogne-Franche-Comté, FranceGenomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, FranceUniversity of Burgundy-Franche Comté, Dijon, Bourgogne-Franche-Comté, FranceDepartmnt of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles; Laure Favier Departmnt of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles; Aurélie Lagrange Departmnt of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles; Romain Boidot Department of Biopathology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles; Philippe Joubert Department of Pathology, Quebec Heart and Lung Institute Research Center, Quebec City, Quebec, Canada PubMed articlesGoogle scholar articles; Caroline Truntzer Platform of Transfer in Biological Oncology, Georges-Francois Leclerc Cancer Center - UNICANCER, Dijon, Bourgogne-Franche-Comté, FranceUMR INSERM 1231, Dijon, Bourgogne-Franche-Comté, FranceGenomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, FranceUniversity of Burgundy-Franche Comté, Dijon, Bourgogne-Franche-Comté, France PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004241
43,Original research: Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors,"Xiaozhen Zhang, Mengyi Lao, Jian Xu, Yi Duan, Hanshen Yang, Muchun Li, Honggang Ying, Lihong He, Kang Sun, Chengxiang Guo, Wen Chen, Haitao Jiang, Xiaoyu Zhang, Xueli Bai, Tingbo Liang","Xiaozhen Zhang Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Jian Xu Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Hanshen Yang Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Honggang Ying Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Kang Sun Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Wen Chen Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Xiaoyu Zhang Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Tingbo Liang Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, ChinaCancer Center, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Mengyi Lao Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Yi Duan Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Muchun Li Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Lihong He Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Chengxiang Guo Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Haitao Jiang Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles; Xueli Bai Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang University, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Zhejiang University, Hangzhou, ChinaCancer Center, Zhejiang University, Hangzhou, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003982
44,Original research: Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab,"Khalid Jazieh, Mohammadhadi Khorrami, Anas Saad, Mohamed Gad, Amit Gupta, Pradnya Patil, Vidya Sankar Viswanathan, Prabhakar Rajiah, Charles J Nock, Michael Gilkey, Pingfu Fu, Nathan A Pennell, Anant Madabhushi","Khalid Jazieh Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles; Anas Saad Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles; Amit Gupta Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles; Vidya Sankar Viswanathan Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles; Charles J Nock Louis Stokes Cleveland VA Medical Center Mental Health Services, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles; Pingfu Fu Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles; Anant Madabhushi Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USALouis Stokes Cleveland VA Medical Center Mental Health Services, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles; Mohammadhadi Khorrami Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles; Mohamed Gad Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles; Pradnya Patil Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles; Prabhakar Rajiah Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles; Michael Gilkey Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles; Nathan A Pennell Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003778
45,Original research: In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies,"Caterina Ieranò, Dario Righelli, Crescenzo D'Alterio, Maria Napolitano, Luigi Portella, Giuseppina Rea, Federica Auletta, Sara Santagata, Anna Maria Trotta, Giuseppe Guardascione, Federica Liotti, Nella Prevete, Piera Maiolino, Antonio Luciano, Antonio Barbieri, Annabella Di Mauro, Cristin Roma, Riziero Esposito Abate, Fabiana Tatangelo, Roberto Pacelli, Nicola Normanno, Rosa Marina Melillo, Stefania Scala","Caterina Ieranò Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Crescenzo D'Alterio Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Luigi Portella Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Federica Auletta Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Anna Maria Trotta Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Federica Liotti Institute of Endocrinology and Experimental Oncology (IEOS), CNR-NA1, Napoli, Italy PubMed articlesGoogle scholar articles; Piera Maiolino Pharmacy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Antonio Barbieri Animal Facility, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Cristin Roma Cell Biology and Biotherapy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Fabiana Tatangelo Pathology, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Nicola Normanno Cell Biology and Biotherapy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Stefania Scala Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Dario Righelli Statistical Sciences, University of Padua, Padua, Italy PubMed articlesGoogle scholar articles; Maria Napolitano Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Giuseppina Rea Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Sara Santagata Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Giuseppe Guardascione Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Nella Prevete Institute of Endocrinology and Experimental Oncology (IEOS), CNR-NA1, Napoli, ItalyTraslational Medical Sciences, University of Naples Federico II, Napoli, Italy PubMed articlesGoogle scholar articles; Antonio Luciano Animal Facility, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Annabella Di Mauro Pathology, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Riziero Esposito Abate Cell Biology and Biotherapy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy PubMed articlesGoogle scholar articles; Roberto Pacelli Advanced Biomedical Sciences, University of Naples Federico II, Napoli, Italy PubMed articlesGoogle scholar articles; Rosa Marina Melillo Institute of Endocrinology and Experimental Oncology (IEOS), CNR-NA1, Napoli, ItalyMolecular Medicine and Medical Biotechnology, University of Naples Federico II, Napoli, Italy PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004032
46,Original research: Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer,"Yuezong Bai, Tong Xie, Zhenghang Wang, Shuang Tong, Xiaochen Zhao, Feilong Zhao, Jinping Cai, Xiaofan Wei, Zhi Peng, Lin Shen","Yuezong Bai Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles; Zhenghang Wang Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles; Xiaochen Zhao Medical Affairs, 3D Medicines, Inc, Shanghai, China PubMed articlesGoogle scholar articles; Jinping Cai Medical Affairs, 3D Medicines, Inc, Shanghai, China PubMed articlesGoogle scholar articles; Zhi Peng Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles; Tong Xie Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles; Shuang Tong Medical Affairs, 3D Medicines, Inc, Shanghai, China PubMed articlesGoogle scholar articles; Feilong Zhao Medical Affairs, 3D Medicines, Inc, Shanghai, China PubMed articlesGoogle scholar articles; Xiaofan Wei Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China PubMed articlesGoogle scholar articles; Lin Shen Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004080
47,Original research: Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies,"Javier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, Assunta Cirella, Alvaro Teijeira, Maria C Ochoa, Maite Alvarez, Iñaki Eguren-Santamaria, Carlos Luri-Rey, Maria E Rodriguez-Ruiz, Xinxin Nie, Lieping Chen, Sonia Guedan, Miguel F Sanamed, Jose Luis Perez Gracia, Ignacio Melero","Javier Glez-Vaz Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, Spain PubMed articlesGoogle scholar articles; Irene Olivera Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, Spain PubMed articlesGoogle scholar articles; Alvaro Teijeira Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, SpainCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles; Maite Alvarez Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, SpainDepartments of Immunology-Immunotherapy and Oncology, Clínica Universidad de Navarra, Pamplona, SpainCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles; Carlos Luri-Rey Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, Spain PubMed articlesGoogle scholar articles; Xinxin Nie Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA PubMed articlesGoogle scholar articles; Sonia Guedan Department of Hematology and Oncology, Hospital Clinic. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles; Jose Luis Perez Gracia Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, SpainDepartments of Immunology-Immunotherapy and Oncology, Clínica Universidad de Navarra, Pamplona, SpainCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles; Arantza Azpilikueta Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, Spain PubMed articlesGoogle scholar articles; Assunta Cirella Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, SpainDepartments of Immunology-Immunotherapy and Oncology, Clínica Universidad de Navarra, Pamplona, Spain PubMed articlesGoogle scholar articles; Maria C Ochoa Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, SpainDepartments of Immunology-Immunotherapy and Oncology, Clínica Universidad de Navarra, Pamplona, SpainCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles; Iñaki Eguren-Santamaria Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, Spain PubMed articlesGoogle scholar articles; Maria E Rodriguez-Ruiz Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, SpainDepartments of Immunology-Immunotherapy and Oncology, Clínica Universidad de Navarra, Pamplona, SpainCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles; Lieping Chen Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USADepartment of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA PubMed articlesGoogle scholar articles; Miguel F Sanamed Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, SpainDepartments of Immunology-Immunotherapy and Oncology, Clínica Universidad de Navarra, Pamplona, SpainCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles; Ignacio Melero Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, SpainNavarra Institute for Health Research (IDISNA), Pamplona, SpainDepartments of Immunology-Immunotherapy and Oncology, Clínica Universidad de Navarra, Pamplona, SpainCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003532
48,Original research: Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy,"Xin Liu, Yixiang Xu, Wei Xiong, Bingnan Yin, Yuqian Huang, Junjun Chu, Changsheng Xing, Chen Qian, Yang Du, Tianhao Duan, Helen Y Wang, Ningyan Zhang, John S. Yu, Zhiqiang An, Rongfu Wang","Xin Liu Keck School of Medicine, University of Southern California, Los Angeles, California, USACenter for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USAInstitute of Biosciences and Technology, College of Medicine, Texas A&M University, Houston, Texas, USA PubMed articlesGoogle scholar articles; Wei Xiong Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA PubMed articlesGoogle scholar articles; Yuqian Huang Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USAXiangya School of Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China PubMed articlesGoogle scholar articles; Changsheng Xing Keck School of Medicine, University of Southern California, Los Angeles, California, USACenter for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA PubMed articlesGoogle scholar articles; Yang Du Keck School of Medicine, University of Southern California, Los Angeles, California, USACenter for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA PubMed articlesGoogle scholar articles; Helen Y Wang Keck School of Medicine, University of Southern California, Los Angeles, California, USACenter for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA PubMed articlesGoogle scholar articles; John S. Yu Neurosurgical Oncology in the Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California, USA PubMed articlesGoogle scholar articles; Rongfu Wang Keck School of Medicine, University of Southern California, Los Angeles, California, USACenter for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USAInstitute of Biosciences and Technology, College of Medicine, Texas A&M University, Houston, Texas, USA PubMed articlesGoogle scholar articles; Yixiang Xu Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA PubMed articlesGoogle scholar articles; Bingnan Yin Keck School of Medicine, University of Southern California, Los Angeles, California, USACenter for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA PubMed articlesGoogle scholar articles; Junjun Chu Keck School of Medicine, University of Southern California, Los Angeles, California, USACenter for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA PubMed articlesGoogle scholar articles; Chen Qian Keck School of Medicine, University of Southern California, Los Angeles, California, USACenter for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA PubMed articlesGoogle scholar articles; Tianhao Duan Keck School of Medicine, University of Southern California, Los Angeles, California, USACenter for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, Texas, USA PubMed articlesGoogle scholar articles; Ningyan Zhang Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA PubMed articlesGoogle scholar articles; Zhiqiang An Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004035
49,Original research: T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion,"Laura T Morton, Tassilo L A Wachsmann, Miranda H Meeuwsen, Anne K Wouters, Dennis F G Remst, Marleen M van Loenen, J H Frederik Falkenburg, Mirjam H M Heemskerk","Laura T Morton Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Miranda H Meeuwsen Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Dennis F G Remst Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; J H Frederik Falkenburg Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Tassilo L A Wachsmann Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Anne K Wouters Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Marleen M van Loenen Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles; Mirjam H M Heemskerk Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003715
50,Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy,"Kristin G Anderson, Shannon K Oda, Breanna M Bates, Madison G Burnett, Magdalia Rodgers Suarez, Susan L Ruskin, Philip D Greenberg","Kristin G Anderson Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAImmunology, University of Washington School of Medicine, Seattle, Washington, USA PubMed articlesGoogle scholar articles; Breanna M Bates Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles; Magdalia Rodgers Suarez Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles; Philip D Greenberg Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAImmunology, University of Washington School of Medicine, Seattle, Washington, USA PubMed articlesGoogle scholar articles; Shannon K Oda Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USABen Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA PubMed articlesGoogle scholar articles; Madison G Burnett Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles; Susan L Ruskin Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003959
51,Generalizable design parameters for soluble T cell receptor-based T cell engagers,"Karen J Froning, Arlene Sereno, Flora Huang, Stephen J Demarest","Karen J Froning Lilly Biotechnology Center, Eli Lilly and Company, San Diego, California, USA PubMed articlesGoogle scholar articles; Flora Huang Lilly Biotechnology Center, Eli Lilly and Company, San Diego, California, USA PubMed articlesGoogle scholar articles; Arlene Sereno Lilly Biotechnology Center, Eli Lilly and Company, San Diego, California, USA PubMed articlesGoogle scholar articles; Stephen J Demarest Lilly Biotechnology Center, Eli Lilly and Company, San Diego, California, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004281
52,Original research: Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression,"Bin-Jin Hwang, Li-Chung Tsao, Chaitanya R Acharya, Timothy Trotter, Pankaj Agarwal, Junping Wei, Tao Wang, Xiao-Yi Yang, Gangjun Lei, Takuya Osada, Herbert Kim Lyerly, Michael A Morse, Zachary Conrad Hartman","Bin-Jin Hwang Surgery, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Chaitanya R Acharya Surgery, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Pankaj Agarwal Surgery, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Tao Wang Surgery, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Gangjun Lei Surgery, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Herbert Kim Lyerly Surgery, Duke University, Durham, North Carolina, USAImmunology, Duke University, Durham, North Carolina, USAPathology, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Zachary Conrad Hartman Surgery, Duke University, Durham, North Carolina, USAPathology, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Li-Chung Tsao Surgery, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Timothy Trotter Surgery, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Junping Wei Surgery, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Xiao-Yi Yang Surgery, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Takuya Osada Surgery, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles; Michael A Morse Surgery, Duke University, Durham, North Carolina, USAMedicine, Duke University, Durham, NC, USA PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003721
53,Original research: CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma,"Galabina Bozhanova, Jehanne Hassan, Lizzie Appleton, Victoria Jennings, Shane Foo, Martin McLaughlin, Charleen ML Chan Wah Hak, Emmanuel C Patin, Eva Crespo-Rodriguez, Gabby Baker, Edward Armstrong, Matthew Chiu, Hardev Pandha, Adel Samson, Victoria Roulstone, Joan Kyula, Richard Vile, Fiona Errington-Mais, Malin Pedersen, Kevin Harrington, Masahiro Ono, Alan Melcher","Galabina Bozhanova Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Lizzie Appleton Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UKImperial College London, London, UK PubMed articlesGoogle scholar articles; Shane Foo Radiotherapy & Imaging, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Charleen ML Chan Wah Hak Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Eva Crespo-Rodriguez Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Edward Armstrong Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Hardev Pandha Oncology, University of Surrey, Guildford, UK PubMed articlesGoogle scholar articles; Victoria Roulstone Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Richard Vile Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles; Malin Pedersen Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Masahiro Ono Imperial College London, London, UK PubMed articlesGoogle scholar articles; Jehanne Hassan Imperial College London, London, UK PubMed articlesGoogle scholar articles; Victoria Jennings Leeds Institute of Medical Research at St. James’s, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles; Martin McLaughlin Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Emmanuel C Patin Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Gabby Baker Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Matthew Chiu Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Adel Samson Leeds Institute of Medical Research at St. James’s, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles; Joan Kyula Translational Immunotherapy/Targeted Therapy Teams, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Fiona Errington-Mais Leeds Institute of Medical Research at St. James’s, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles; Kevin Harrington Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles; Alan Melcher Institute of Cancer Research, London, UK PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004410
54,"Original research: Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors","Rocio Garcia-Carbonero, Miriam Bazan-Peregrino, Marta Gil-Martín, Rafael Álvarez, Teresa Macarulla, Maria C Riesco-Martinez, Helena Verdaguer, Carmen Guillén-Ponce, Martí Farrera-Sal, Rafael Moreno, Ana Mato-Berciano, Maria Victoria Maliandi, Silvia Torres-Manjon, Marcel Costa, Natalia del Pozo, Jaime Martínez de Villarreal, Francisco X Real, Noemí Vidal, Gabriel Capella, Ramon Alemany, Emma Blasi, Carmen Blasco, Manel Cascalló, Ramon Salazar","Rocio Garcia-Carbonero Oncology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), UCM, CNIO, CIBERONC, Madrid, Spain PubMed articlesGoogle scholar articles; Marta Gil-Martín Medical Oncology Department, Institut Catala d'Oncologia, L’Hospitalet de Llobregat, Barcelona, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles; Teresa Macarulla Vall d'Hebron University Hospital & Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain PubMed articlesGoogle scholar articles; Helena Verdaguer Vall d'Hebron University Hospital & Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain PubMed articlesGoogle scholar articles; Martí Farrera-Sal VCN Biosciences, Sant Cugat del Vallès, Barcelona, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, SpainProCure Program, Institut Catala d'Oncologia, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles; Ana Mato-Berciano VCN Biosciences, Sant Cugat del Vallès, Barcelona, Spain PubMed articlesGoogle scholar articles; Silvia Torres-Manjon Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, SpainProCure Program, Institut Catala d'Oncologia, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles; Natalia del Pozo Epithelial Carcinogenesis Group, Molecular Oncology Programme, Spanish National Cancer Research Centre-CNIO, Madrid, Spain PubMed articlesGoogle scholar articles; Francisco X Real Epithelial Carcinogenesis Group, Molecular Oncology Programme, Spanish National Cancer Research Centre-CNIO, Madrid, SpainDepartament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain PubMed articlesGoogle scholar articles; Gabriel Capella Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, SpainHereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, L’Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain, Spain PubMed articlesGoogle scholar articles; Emma Blasi VCN Biosciences, Sant Cugat del Vallès, Barcelona, Spain PubMed articlesGoogle scholar articles; Manel Cascalló VCN Biosciences, Sant Cugat del Vallès, Barcelona, Spain PubMed articlesGoogle scholar articles; Miriam Bazan-Peregrino VCN Biosciences, Sant Cugat del Vallès, Barcelona, Spain PubMed articlesGoogle scholar articles; Rafael Álvarez Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain PubMed articlesGoogle scholar articles; Maria C Riesco-Martinez Oncology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), UCM, CNIO, CIBERONC, Madrid, Spain PubMed articlesGoogle scholar articles; Carmen Guillén-Ponce Hospital Ramon y Cajal, Madrid, Spain PubMed articlesGoogle scholar articles; Rafael Moreno Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, SpainProCure Program, Institut Catala d'Oncologia, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles; Maria Victoria Maliandi VCN Biosciences, Sant Cugat del Vallès, Barcelona, Spain PubMed articlesGoogle scholar articles; Marcel Costa Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, SpainProCure Program, Institut Catala d'Oncologia, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles; Jaime Martínez de Villarreal Epithelial Carcinogenesis Group, Molecular Oncology Programme, Spanish National Cancer Research Centre-CNIO, Madrid, Spain PubMed articlesGoogle scholar articles; Noemí Vidal Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain PubMed articlesGoogle scholar articles; Ramon Alemany Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, SpainProCure Program, Institut Catala d'Oncologia, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles; Carmen Blasco VCN Biosciences, Sant Cugat del Vallès, Barcelona, Spain PubMed articlesGoogle scholar articles; Ramon Salazar Medical Oncology Department, Institut Catala d'Oncologia, L’Hospitalet de Llobregat, Barcelona, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L’Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain, SpainUniversity of Barcelona, Barcelona, Spain PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003255
55,Original research: Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer,"Jacob P van Vloten, Kathy Matuszewska, Mark A A Minow, Jessica A Minott, Lisa A Santry, Madison Pereira, Ashley A Stegelmeier, Thomas M McAusland, Elaine M Klafuric, Khalil Karimi, Joseph Colasanti, D Grant McFadden, James J Petrik, Byram W Bridle, Sarah K Wootton","Jacob P van Vloten Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; Mark A A Minow Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; Lisa A Santry Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; Ashley A Stegelmeier Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; Elaine M Klafuric Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; Joseph Colasanti Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; James J Petrik Department of Biomedical Sciences, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; Sarah K Wootton Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; Kathy Matuszewska Department of Biomedical Sciences, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; Jessica A Minott Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; Madison Pereira Department of Biomedical Sciences, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; Thomas M McAusland Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; Khalil Karimi Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles; D Grant McFadden Biodesign Institute, Arizona State University, Tempe, Arizona, USA PubMed articlesGoogle scholar articles; Byram W Bridle Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004335
56,Original research: Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis,"Tianyu Tang, Xing Huang, Gang Zhang, Minghao Lu, Zhengtao Hong, Meng Wang, Junming Huang, Xiao Zhi, Tingbo Liang","Tianyu Tang Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles; Gang Zhang Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles; Zhengtao Hong Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles; Junming Huang Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles; Tingbo Liang Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles; Xing Huang Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles; Minghao Lu Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles; Meng Wang Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles; Xiao Zhi Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004129
57,Original research: PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8+ T cell-dependent antitumor immunity and abscopal effect after local irradiation,"Yi Na Yoon, Eunju Lee, Young-Ju Kwon, Jeong-An Gim, Tae-Jin Kim, Jae-Sung Kim","Yi Na Yoon Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Nowon-gu, Seoul, The Republic of Korea PubMed articlesGoogle scholar articles; Young-Ju Kwon Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Nowon-gu, Seoul, The Republic of KoreaRadiological and Medico-Oncological Sciences, University of Science and Technology, Yuseong-gu, Daejeon, The Republic of Korea PubMed articlesGoogle scholar articles; Tae-Jin Kim Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Nowon-gu, Seoul, The Republic of Korea PubMed articlesGoogle scholar articles; Eunju Lee Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Nowon-gu, Seoul, The Republic of KoreaDepartment of Biochemistry and Molecular Biology, College of Medicine, Korea University, Seongbuk-gu, The Republic of Korea PubMed articlesGoogle scholar articles; Jeong-An Gim Medical Science Research Center, College of Medicine, Korea University, Seoul, The Republic of Korea PubMed articlesGoogle scholar articles; Jae-Sung Kim Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Nowon-gu, Seoul, The Republic of KoreaRadiological and Medico-Oncological Sciences, University of Science and Technology, Yuseong-gu, Daejeon, The Republic of Korea PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003762
58,Original research: Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer,"Daniel Alonso-Miguel, Guillermo Valdivia, Diego Guerrera, Maria Dolores Perez-Alenza, Stanislav Pantelyushin, Angela Alonso-Diez, Veronique Beiss, Steven Fiering, Nicole F Steinmetz, Maria Suarez-Redondo, Johannes vom Berg, Laura Peña, Hugo Arias-Pulido","Daniel Alonso-Miguel Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles; Diego Guerrera Institute of Laboratory Animal Science, University of Zurich, Schlieren, Switzerland PubMed articlesGoogle scholar articles; Stanislav Pantelyushin Institute of Laboratory Animal Science, University of Zurich, Schlieren, Switzerland PubMed articlesGoogle scholar articles; Veronique Beiss Department of Biomedical Engineering, Case Western Reserve University School of Medicine, Cleveland, Ohio, USADepartment of NannoEngineering, University of California San Diego, La Jolla, California, USA PubMed articlesGoogle scholar articles; Nicole F Steinmetz Department of Biomedical Engineering, Case Western Reserve University School of Medicine, Cleveland, Ohio, USADepartment of NannoEngineering, University of California San Diego, La Jolla, California, USADepartment of Radiology, University of California San Diego, La Jolla, California, USADepartment of Bioengineering, University of California San Diego, La Jolla, California, USAMoores Cancer Center, University of California San Diego, La Jolla, California, USACenter for Nano-ImmunoEngineering, University of California San Diego, La Jolla, California, USAInstitute for Materials Discovery and Design, University of California San Diego, La Jolla, California, USA PubMed articlesGoogle scholar articles; Johannes vom Berg Institute of Laboratory Animal Science, University of Zurich, Schlieren, Switzerland PubMed articlesGoogle scholar articles; Hugo Arias-Pulido Department of Microbiology and Immunology, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Health, Dartmouth College Geisel School of Medicine, Lebanon, New Hampshire, USA PubMed articlesGoogle scholar articles; Guillermo Valdivia Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles; Maria Dolores Perez-Alenza Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles; Angela Alonso-Diez Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles; Steven Fiering Department of Microbiology and Immunology, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Health, Dartmouth College Geisel School of Medicine, Lebanon, New Hampshire, USA PubMed articlesGoogle scholar articles; Maria Suarez-Redondo Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles; Laura Peña Department of Animal Medicine, Surgery and Pathology, Mammary Oncology Unit, Veterinary Teaching Hospital, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004044
59,Original research: Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity,"Jin-Yan Wang, Hengyu Chen, Shu-Zhen Dai, Feng-Ying Huang, Ying-Ying Lin, Cai-Chun Wang, Lei Li, Wu-Ping Zheng, Guang-Hong Tan","Jin-Yan Wang Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Hainan Medical University; Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical University, Haikou, Hainan, China PubMed articlesGoogle scholar articles; Shu-Zhen Dai Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Hainan Medical University; Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical University, Haikou, Hainan, China PubMed articlesGoogle scholar articles; Ying-Ying Lin Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Hainan Medical University; Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical University, Haikou, Hainan, China PubMed articlesGoogle scholar articles; Lei Li Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China PubMed articlesGoogle scholar articles; Guang-Hong Tan Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Hainan Medical University; Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical University, Haikou, Hainan, China PubMed articlesGoogle scholar articles; Hengyu Chen Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Hainan Medical University; Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical University, Haikou, Hainan, ChinaDepartment of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China PubMed articlesGoogle scholar articles; Feng-Ying Huang Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Hainan Medical University; Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical University, Haikou, Hainan, China PubMed articlesGoogle scholar articles; Cai-Chun Wang Department of Respiratory Diseases, The First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou, Hainan, China PubMed articlesGoogle scholar articles; Wu-Ping Zheng Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Hainan Medical University; Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical University, Haikou, Hainan, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003950
60,Original research: Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression,"Adam Nelson, Simon Gebremeskel, Brian D Lichty, Brent Johnston","Adam Nelson 
Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada
 PubMed articlesGoogle scholar articles; Brian D Lichty 
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
 PubMed articlesGoogle scholar articles; Simon Gebremeskel 
Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada
 PubMed articlesGoogle scholar articles; Brent Johnston 
Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada
 PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003923
61,Original research: Ultrasound combined with nanobubbles promotes systemic anticancer immunity and augments anti-PD1 efficacy,"Jianjun Hu, Jiangyi He, Yunlong Wang, Yang Zhao, Kejing Fang, Yan Dong, Yanrong Chen, Yue Zhang, Chi Zhang, Hongwei Wang, Jun Tan, Junyi Wang, Ruiyang Zi, Chengxiang Liu, Houjie Liang, Yanli Guo, Juanjuan Ou","Jianjun Hu Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Yunlong Wang Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Kejing Fang Department of Ultrasound, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Yanrong Chen Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Chi Zhang Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Jun Tan Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Ruiyang Zi Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Houjie Liang Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Juanjuan Ou Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Jiangyi He Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Yang Zhao Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Yan Dong Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Yue Zhang Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Hongwei Wang Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Junyi Wang Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Chengxiang Liu Department of Oncology, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles; Yanli Guo Department of Ultrasound, Army Medical University, Chongqing, China PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003408
62,Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitis,"Christopher Ma, Rish K Pai, David F Schaeffer, Jonathan Krell, Leonardo Guizzetti, Stefanie C McFarlane, John K MacDonald, Won-Tak Choi, Roger M Feakins, Richard Kirsch, Gregory Y Lauwers, Reetesh K Pai, Christophe Rosty, Amitabh Srivastava, Joanna C. Walsh, Brian G Feagan, Vipul Jairath","Christopher Ma Division of Gastroenterology & Hepatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaAlimentiv Inc, London, Ontario, Canada PubMed articlesGoogle scholar articles; David F Schaeffer Division of Anatomic Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles; Leonardo Guizzetti Alimentiv Inc, London, Ontario, Canada PubMed articlesGoogle scholar articles; John K MacDonald Alimentiv Inc, London, Ontario, Canada PubMed articlesGoogle scholar articles; Roger M Feakins Department of Histopathology, Royal Free Hospital, London, UK PubMed articlesGoogle scholar articles; Gregory Y Lauwers Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USADepartments of Pathology and Oncologic Sciences, University of South Florida, Tampa, Florida, USA PubMed articlesGoogle scholar articles; Christophe Rosty Faculty of Medicine, The University of Queensland, Brisbane, Queensland, AustraliaEnvoi Specialist Pathologists, Brisbane, Queensland, AustraliaDepartment of Pathology, University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles; Joanna C. Walsh Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada PubMed articlesGoogle scholar articles; Vipul Jairath Alimentiv Inc, London, Ontario, CanadaDepartment of Epidemiology and Biostatistics, Western University, London, Ontario, CanadaDivision of Gastroenterology, Schulich School of Medicine, Western University, London, Ontario, Canada PubMed articlesGoogle scholar articles; Rish K Pai Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, Arizona, USA PubMed articlesGoogle scholar articles; Jonathan Krell Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK PubMed articlesGoogle scholar articles; Stefanie C McFarlane Alimentiv Inc, London, Ontario, Canada PubMed articlesGoogle scholar articles; Won-Tak Choi Department of Pathology, University of California San Francisco, San Francisco, California, USA PubMed articlesGoogle scholar articles; Richard Kirsch Department of Laboratory Medicine and Pathobiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles; Reetesh K Pai Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA PubMed articlesGoogle scholar articles; Amitabh Srivastava Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles; Brian G Feagan Alimentiv Inc, London, Ontario, CanadaDepartment of Epidemiology and Biostatistics, Western University, London, Ontario, CanadaDivision of Gastroenterology, Schulich School of Medicine, Western University, London, Ontario, Canada PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e004560
63,Role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes and toxicity in patients with cancer treated with immunotherapy,"Yeonggyeong Park, Min Jeong Kim, Yoonhee Choi, Na Hyun Kim, Leeseul Kim, Seung Pyo Daniel Hong, Hyung-Gyo Cho, Emma Yu, Young Kwang Chae","Yeonggyeong Park 
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
 PubMed articlesGoogle scholar articles; Yoonhee Choi 
Department of Internal Medicine, NewYork-Presbyterian Queens, Flushing, New York, USA
 PubMed articlesGoogle scholar articles; Leeseul Kim 
Department of Internal Medicine, AMITA Health Saint Francis Hospital Evanston, Evanston, Illinois, USA
 PubMed articlesGoogle scholar articles; Hyung-Gyo Cho 
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
 PubMed articlesGoogle scholar articles; Young Kwang Chae 
Department of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
 PubMed articlesGoogle scholar articles; Min Jeong Kim 
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
 PubMed articlesGoogle scholar articles; Na Hyun Kim 
Department of Internal Medicine, AMITA Health Saint Joseph Hospital Chicago, Chicago, Illinois, USA
 PubMed articlesGoogle scholar articles; Seung Pyo Daniel Hong 
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
 PubMed articlesGoogle scholar articles; Emma Yu 
Department of Medicine, Northwestern University, Chicago, Illinois, USA
 PubMed articlesGoogle scholar articles",https://jitc.bmj.com/content/10/3/e003566
64,Correction: Ultrasound combined with nanobubbles promotes systemic anticancer immunity and augments anti-PD1 efficacy,,,https://jitc.bmj.com/content/10/3/e003408corr1
65,Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset,,,https://jitc.bmj.com/content/10/3/e003385corr1
66,Correction: MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy,,,https://jitc.bmj.com/content/10/3/e002029corr1
67,Correction: Computational image features of immune architecture is associated with clinical benefit and survival in gynecological cancers across treatment modalities,,,https://jitc.bmj.com/content/10/3/e003833corr1
68,Correction: Chemical augmentation of mitochondrial electron transport chains tunes T cell activation threshold in tumors,,,https://jitc.bmj.com/content/10/3/e003958corr1
69,Correction: Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1,,,https://jitc.bmj.com/content/10/3/e003224corr1
70,Correction: PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells,,,https://jitc.bmj.com/content/10/3/e002500corr1
71,Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition,,,https://jitc.bmj.com/content/10/3/e001931corr2
